Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 33074. Отображено 100.
01-03-2012 дата публикации

BIOLOGICALLY ACTIVE COMPOSITIONS FROM Schisandra chinensis FOR TREATING COLORECTAL CANCER

Номер: US20120052142A1
Автор: John Noel GNABRE
Принадлежит: Dr Chang Naturals LLC

A biologically active composition to treat colorectal cancer includes an extract of the plant Schisandra chinensis and a suitable pharmaceutical formulation. The extract can be at least one of gomisin A, angeloylgomisin H, deoxyschisandrin and gomisin N, showing activities against human tumor cell line HT-29 in the range of about 716 μM to about 43 μM. A suitable pharmaceutical formulation can be any one of a pill, a tablet, a capsule, a liquid solution, a liquid suspension, a powder, an intravenous solution, a gel and a suppository form. The extract is prepared by grinding the dried berries, extracting with hexane, extracting the marc with dichloromethane, extracting the dichloromethane soluble fraction with ethyl acetate, removing fatty materials in the dichloromethane-ethyl acetate soluble fraction with hexane, and fractionating the total hexane insoluble material extract using analytical high performance liquid chromatography equipped with automated repeat injection/collection cycles.

Подробнее
Номер записи: 1
29-03-2012 дата публикации

Method Of Obtaining Antioxidant From Roasted Coffee Beans, The Antioxidant Thus Obtained, And Food Containing The Same

Номер: US20120076907A1
Автор: Kazuto Ozaki, Shigeyoshi Fujii
Принадлежит: Individual

An antioxidant originating in coffee beans is provided. A method which comprises contacting a water extract of roasted coffee or an aqueous solution of the extract with an adsorbent and then eluting an antioxidant adsorbed by the adsorbent with an organic solvent or an aqueous organic solvent.

Подробнее
Номер записи: 2
26-07-2012 дата публикации

Schisandrae fructus extracts for inhibition or prevention of h1n1 influenza virus infection and its application thereof

Номер: US20120189719A1
Автор: An-rong Lee, Ann Chen, Chen-Wen Yao, Chi-Hong Chu, Chiao-Ying Chien, Chien-Yi Pai, Kuo-Yuan Hwa, Wen-Hsin Huang, Wen-Liang Chang
Принадлежит: NATIONAL DEFENSE MEDICAL CENTER

Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

Подробнее
Номер записи: 3
20-09-2012 дата публикации

Profiles of lipid proteins and inhibiting HMG-CoA reductase

Номер: US20120237626A9
Автор: Afa Palu, Bing-Nan Zhou, Claude Jensen, Mian Wang, Stephen Story
Принадлежит: Individual

The present invention comprises methods and compositions for improving profiles of lipid proteins, reducing low-density lipoprotein levels, increasing high-density lipoprotein levels, decreasing the absorption of fatty acids across the intestinal epithelium and inhibiting HMG-CoA Reductase in living organisms utilizing Morinda citrifolia L activity in mammals, including humans.

Подробнее
Номер записи: 4
29-11-2012 дата публикации

Immunostimulating Agent and Method for Production Thereof

Номер: US20120301505A1
Автор: Kazuya Iwai, Keiko Furuya, Michihiro Takagi, Nanaka Gotoda, Takemi Ueda
Принадлежит: Individual

The object is to provide: a safe immunomodulating agent which can be used as a pharmaceutical or a food material; a method for production of the immunomodulating agent; and a novel application of a coffee extract residue. Disclosed is an immunomodulating agent comprising a coffee extract as an active ingredient. Preferably, the coffee extract is an extract containing arabinogalactan. The immunomodulating effect of the immunomodulating agent relies on the promotion of the proliferation of an immunocompetent cell such as a macrophage. The immunocompetent cell is preferably any one selected from a macrophage like strain RAW264 or J774.1, a murine splenocyte, a murine peritoneal macrophage and a murine dendrocyte. A composition containing the immunomodulating agent can be used as a composition such as a pharmaceutical composition, a food composition and a cosmetic composition.

Подробнее
Номер записи: 5
21-03-2013 дата публикации

METHODS AND COMPOSITIONS FOR BONE AND CARTILAGE REPAIR

Номер: US20130071359A1
Автор: Matheson Graham, Walsh William
Принадлежит: CIMTECH Pty Limited

Biologically active extract of L. and compositions comprising the extract are described. The invention also provides therapeutic uses of the extract and compositions, in particular for promoting healing of bone and cartilage injuries, and the promotion of bone and cartilage formation. 141-. (canceled)42Hibiscus tiliaceus. A biologically active extract of L. , wherein the extract is prepared using and/or comprises a plant based oil.43. An extract of claim 42 , wherein the extract is derived from one or more of a bark claim 42 , leaf claim 42 , vine claim 42 , bean claim 42 , husk or nut.44Hibiscus tiliaceus. An extract of claim 42 , wherein the L. extract is derived from bark.45. An extract of claim 42 , wherein the plant based oil is derived from plant seeds or fruit.46Cocos nucifera.. An extract of claim 42 , wherein the plant based oil is derived from47Cocos nuciferaCocos nuciferaCocos nuciferaCocos nuciferaCocos nucifera. An extract of claim 46 , wherein the oil is virgin oil claim 46 , refined oil claim 46 , hydrogenated oil or fractionated oil.48. A composition comprising an extract according to claim 42 , and one or more pharmaceutically acceptable carriers claim 42 , diluents and/or excipients for the treatment of bone or cartilage injury and/or the promotion of bone or cartilage formation claim 42 , repair or regeneration.49. A composition of claim 48 , wherein the composition is administered topically or parenterally.50. A method for promoting the formation claim 48 , repair or regeneration of bone or cartilage in a subject claim 48 , the method comprising administering to the subject in need thereof an effective amount of{'i': 'Hibiscus tiliaceus', '(a) a composition comprising a biologically active extract of L., wherein the extract is prepared using and/or comprises a plant based oil, and one or more pharmaceutically acceptable carriers, diluents and/or excipients, or'}(b) osteoblasts, osteoblastic progenitor cells, or bone segments or fragments cultured ...

Подробнее
Номер записи: 6
21-03-2013 дата публикации

Oral Formulations For Promoting Cellular Purification

Номер: US20130071369A1
Автор: Barger Jamie Louis, BARTLETT Mark, Ferguson Scott B., Mastaloudis Angela, Prolla Tomas Alberto, Weindruch Richard, Wood Steve
Принадлежит: NSE Products, Inc.

An oral formulation includes a plurality of agents that promote cellular detoxification. Agents can be included that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject, wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants, and at least one gene encoding cellular detoxifiers. In addition, at least one of the plurality of agents attenuates inflammation. 1. An oral formulation comprising a plurality of agents that modulate expression of Nrf2-associated genes upon ingestion of the oral formulation by a subject , wherein the Nrf2-associated genes include at least one gene encoding intrinsic antioxidants , and at least one gene encoding cellular detoxifiers , and wherein at least one of the plurality of agents attenuates inflammation.2. The oral formulation of claim 1 , wherein the Nrf2-associated genes are selected from the group consisting of NFE2L2 claim 1 , GCLM claim 1 , GCLC claim 1 , GSR claim 1 , GSTA1 claim 1 , GPX1 claim 1 , GPX4 claim 1 , HMOX1 claim 1 , NQO1 claim 1 , SRXN1 claim 1 , SQSTM1 claim 1 , SOD1 claim 1 , UGT1A6 claim 1 , NOS2 claim 1 , NOS3 claim 1 , and PTGS2.3. The oral formulation of claim 2 , wherein at least one of the plurality of agents substantially reverses an age-related change in expression of at least one of the Nrf2-associated genes.4. The oral formulation of claim 1 , wherein the plurality of agents combine to modulate expression of at least five Nrf2-associated genes.5. The oral formulation of claim 1 , wherein at least one of the plurality of agents upregulates a gene encoding intrinsic antioxidants.6. The oral formulation of claim 1 , wherein at least one of the plurality of agents upregulates a gene encoding cellular detoxifiers.7. The oral formulation of claim 1 , wherein at least one of the plurality of agents stimulates autophagy in a tissue of the subject.8. The oral formulation of claim 1 , wherein the plurality of agents include at least two ...

Подробнее
Номер записи: 7
21-03-2013 дата публикации

BATHING COMPOSITION AND METHOD FOR PREPARING SAME

Номер: US20130071376A1
Автор: Lee Dong-Joo
Принадлежит:

The present invention relates to a composition for bath additives characterized in that the composition is obtained by a process comprising subjecting herbal materials comprising 10˜25% by weight of , 10˜20% by weight of , 5˜15% by weight of , 1˜20% by weight of , 1˜15% by weight of , 1˜15% by weight of , 1˜15% by weight of -, 1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials, to liquid phase fermentation with which is anaerobic, to obtain a culture, separating sludge from the resulting culture, drying, sterilizing and pulverizing the culture to give a pulverized sludge, and a process for preparing the same. 1Zizania latifolia,Artemisia capillaries,Houttuynia cordata,Saururus chinensis,Leonurus sibiricus,Angelica gigas,Coix lachrymajobi,Plantago asiaticaRhododendron brachycarpumBacillus subtilis. A composition for bath additives obtained by subjecting medicinal herb materials comprising 10˜25% by weight of 10˜20% by weight of 5˜15% by weight of 1˜20% by weight of 1˜15% by weight of 1˜15% by weight of 1˜15% by weight of -1˜10% by weight of and 1˜10% by weight of , based on the total dry weight of the above herb materials , to liquid phase fermentation with which is anaerobic , to obtain a culture , separating sludge from the resulting culture , drying , sterilizing and pulverizing the culture to give a pulverized sludge.2. The composition for bath additives as claimed in wherein the liquid phase fermentation is performed at a temperature of 30˜40° C. for 50˜100 days.3Achillea sibirica,Rumex crispus, andLithospermum erythrorhizon.. The composition for bath additives as claimed in wherein the above medicinal herb materials further comprise 1˜10% by weight of Saliconia herbacea claim 1 , 7˜17% by weight of 5˜15% by weight of 1˜10% by weight of4. A composition for bath additives characterized in that the composition is obtained by a process comprising:{'i': Zizania latifolia,', 'Artemisia capillaries,', 'Houttuynia ...

Подробнее
Номер записи: 8
21-03-2013 дата публикации

COMPOSITIONS FOR SKIN DISEASE OR DISORDERS

Номер: US20130071502A1
Автор: CHANTELOUBE Francoise, Loiseau Alain, PETIT Virginie, SEGOND Caroline, THERON Eric
Принадлежит: BAYER CONSUMER CARE AG

Medicaments or cosmetic compositions for the treatment or alleviation of skin or mucous membrane diseases or disorders related to an enhanced level of anti-microbial peptides or proteins comprising plant extracts, which may comprise polyphenols. 16-. (canceled)7Tambourissa. A method for treating skin disorders or mucous membrane disorders associated with conditions selected from the group consisting of rosacea , acne , couperosis , erythrosis , telangiectasia , herpes , mouth infections , vaginal infections , sebaceous microbial infections , baby rash , dandruff , skin redness , skin blotchiness , atopic dermatitis , psoriasis , acanthosis , solar erythemas , after shave irritation , and itching comprising the step of administering a topical composition comprising plant extract to a patient in need thereof.8. (canceled)9TambourissaTambourissa trichophylla, Tambourissa microphylla, Tambourissa religiosaTambourissa capuronii.. The method of claim 7 , wherein the plant extract is an extract of or10TambourissaTambourissa trichophylla.. The method of claim 7 , wherein the plant extract is an extract of11Tambourissa. The method of claim 7 , wherein the topical composition comprises from about 0.01% to about 10% by weight of the plant extract. This invention relates to medicaments and cosmetic compositions comprising plant extracts that in turn comprise polyphenols for the treatment or alleviation of skin or mucous membrane diseases or disorders related to an enhanced level of anti-microbial peptides or proteins. This invention also relates to processes for preparing a plant extract, the extract itself, and uses of the extract.The genus belongs to the Monimiaceae family and comprises about 43 species found throughout the western islands of the Indian Ocean, such as Madagascar, Comoros and the Mascarenes islands (Mauritius and Reunion). The various species tend to show endemic specificity as most of them are localized in only one island and in only one habitat.(Baker) ...

Подробнее
Номер записи: 9
28-03-2013 дата публикации

ADAPTOGENIC ACTIVITY OF LABISIA PUMILA EXTRACT

Номер: US20130078323A1
Автор: Bani Sarang, Chandan Balkrishan, Chauhan Prashant Singh, Gupta Bishan Dutt, Gupta Devinder Kumar, Koul Surrinder, Kour Kiranjeet, Lal Shankar, Marnickavasagar Rajendran, Pandey Anjali, Sangwan Payarelal, Sharma Neelam, Singh Kuldeep
Принадлежит: HOLISTA BIOTECH SDN. BHD.

The present invention provides a process of extracting the leaves of with water into a free flowing powder using accelerated solvent system and drying. The invention also relates to the immunopotentiating effects of the extract against stress. The extract has effects on fatigue, hypoxia time, potentiation of swimming endurance, bod weight, weight of the thymus and spleen and levels of CD244+ NK cells, CD4+ and CD8+ T cells, expression of ThI cytokines IL-2 and IFN-gamma, corticosterone, glutathione, alanine aminotransferase and lipid peroxidation levels. 1Labisia pumila. A process of extracting the leaves of with water into a free flowing powder using accelerated solvent system and drying.2Labisia pumila. The process as claimed in claim 1 , wherein the aqueous leaf extract is administered systemically and orally.3Labisia pumila. The process as claimed in claim 1 , wherein adaptogen activity of the aqueous leaf extract provides anti-fatigue effect with maximum effect at 100 mg/kg p.o.4Labisia pumila. The process as claimed in claim 1 , wherein adaptogen activity of the aqueous leaf extract provides enhancement in the Hypoxia time.5Labisia pumila. The process as claimed in claim 1 , wherein adaptogen activity of the aqueous leaf extract provides higher potentiation in swimming endurance.6Labisia pumila. The process as claimed in claim 1 , wherein adaptogen activity of the aqueous leaf extract provides recovery of restraint stress induced depletion of CD244+ NK cells.7Labisia pumila. The process as claimed in claim 6 , wherein adaptogen activity of the aqueous leaf extract provides recovery in the restraint stress induced depleted CD4+ and CD8+ T cell population.8Labisia pumila. The process as claimed in claim 7 , wherein adaptogen activity of the aqueous leaf extract provides increased expression of Th1 cytokines IL-2 and IFN-gamma in restraint stress induced experimental animals.9Labisia pumila. The process as claimed in claim 1 , wherein adaptogen activity of the ...

Подробнее
Номер записи: 10
28-03-2013 дата публикации

Method and Composition for Administering Bioactive Compounds Derived From Morinda Citrifolia

Номер: US20130079380A1
Автор: Afa K. Palu, Bing-Nan Zhou, Brett J. West, Chen Su, Claude Jarakae Jensen, Shixin Deng, Stephen Story
Принадлежит: MORINDA HOLDINGS Inc

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

Подробнее
Номер записи: 11
04-04-2013 дата публикации

PHARMACEUTICAL COMPOSITION

Номер: US20130084342A1
Автор: NAKAMORI Toshio
Принадлежит:

A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. 1. A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising:1.5 parts by weight powdered fennel;2.0 parts by weight powdered rhubarb;1.0 part by weight powdered glycyrrhiza;2.0 parts by weight powdered phellodendron bark;1.0 part by weight powdered zedoary;1.5 parts by weight powdered picrasma wood;1.0 part by weight powdered matricaria chamomilla;1.5 parts by weight powdered geranium herb;1.0 part by weight powdered ginseng;1.5 parts by weight powdered citrus unshiu peel;1.0 part by weight powdered scutellaria root;1.0 part by weight powdered magnolia bark;2.0 parts by weight powdered oyster shell;1.0 part by weight powdered cyperus rhizome;2.0 parts by weight powdered platycodon root;2.0 parts by weight powdered melia azedarach;1.0 part by weight powdered enidium rhizome;2.0 parts by weight sodium bicarbonate; and4.0 parts ...

Подробнее
Номер записи: 12
25-04-2013 дата публикации

FRUIT AND VEGETABLE-DERIVED COMPOSITIONS FIELD OF THE INVENTION

Номер: US20130101691A1
Автор: Kahana Yehuda, Maimon Rami, Perry Chaim
Принадлежит: Secret of Youth Ltd

This invention provides fruit and vegetable-derived compositions comprising a fruit or vegetable derivative of inter alia, at least one Beta, Capsicum and Malus species, wherein the composition is at a pH in the range of about 3 to about 6.5. The invention further provides for process for the production of the same and uses thereof. 1. A fruit and vegetable-derived composition comprising a fruit or vegetable derivative of at least one Beta , Capsicum and Malus species at a pH in the range of about 3 to about 6.5.2Citrus limonCitrus paradise. The fruit and vegetable-derived composition of claim 1 , further comprising a derivative of at least one of Solanum claim 1 , Cucumis claim 1 , a claim 1 , a claim 1 , and a Prunus.3. The fruit and vegetable-derived composition of claim 2 , further comprising a derivative of a Diospyros.4Citrus maxima.. The fruit and vegetable-derived composition of claim 2 , further comprising a derivative of a5Carica papaya.. The fruit and vegetable-derived composition of claim 2 , further comprising a derivative of a6. The fruit and vegetable-derived composition of wherein said fruit derivative comprises a pulp and a seed of said fruit and optionally a zest claim 1 , a peel or a combination thereof.7. The fruit and vegetable-derived composition of wherein said vegetable derivative comprises a pulp of said vegetable and a peel of said vegetable.8. A method for the treatment or prophylaxis of a dermatologic disease or disorder in a mammal claim 1 , comprising topically applying an effective amount of the fruit and vegetable-derived composition of to the mammal.9. The method according to claim 8 , wherein said dermatologic disease or disorder is psoriasis claim 8 , acne claim 8 , seborrhea claim 8 , eczema claim 8 , skin erosion claim 8 , skin inflammation claim 8 , hair loss claim 8 , diabetic ulcers or lesions claim 8 , wrinkles claim 8 , or skin fissures.10. The method according to claim 8 , wherein said dermatologic disease or disorder is ...

Подробнее
Номер записи: 13
02-05-2013 дата публикации

Compositions for the treatment of gynaecological disorders

Номер: US20130108717A1
Автор: Stefano Togni
Принадлежит: Indena SpA

The present invention relates to a combination of a rhatany extract, 18β-glycyrrhetic acid, in free form and in complexes with phospholipids, and Zanthoxylum bungeanum extract, for the topical treatment of gynaecological disorders, especially vulvovaginal infections.

Подробнее
Номер записи: 14
16-05-2013 дата публикации

Herbal composition for treating cancer

Номер: US20130122035A1
Автор: Yu-Hwa Peter SHENG
Принадлежит: Individual

An herbal composition and a method for treating cancer, especially for lung cancer, useful for enhancing the quality of life.

Подробнее
Номер записи: 15
16-05-2013 дата публикации

PHYLLANTHUS AMARUS COMPOSITIONS AND METHOD OF EXTRACTING SAME

Номер: US20130122119A1
Автор: Ghosal Shibnath, Kalidindi Sanyasi R., Veeraragavan Muruganandam
Принадлежит: NATREON, INC.

An enriched hydrolyzable tannin blend derived from is provided. An optimized aqueous extraction method for is provided to maximize the levels of bioactive hydrolyzable tannins including corilagin, geraniin, nirurin and other low molecular weight hydrolyzable tannoids. The method produces a extract containing a hydrolyzable tannin blend as an amorphous dry powder. In an embodiment, the extract contains 7-13% by weight corilagin, 3.5-10% nirurin, 1-2% geraniin, and 9-20% low molecular weight hydrolyzable tannoids. In another embodiment, the extract contains 12-20% geraniin and 12-20% low molecular weight hydrolyzable tannoids. Potential uses of said enriched hydrolyzable tannin compositions for hepatoprotection in a human subject are described herein. 1Phyllanthus amarus. A extract composition comprising a hydrolyzable tannin blend including about 3-20% by weight of corilagin based on the total weight of the extract.2Phyllanthus amarus. A extract composition comprising a hydrolyzable tannin blend including about 1-25% by weight of geraniin based on the total weight of the extract.3Phyllanthus amarus. A extract composition comprising a hydrolyzable tannin blend including about 3-20% by weight corilagin based on the total weight of the extract , about 3.5-10% by weight nirurin based on the total weight of the extract , about 1-3% by weight geraniin based on the total weight of the extract , and about 9-20% by weight low molecular weight hydrolyzable tannoids based on the total weight of the extract.4. A pharmaceutical or nutraceutical composition comprising the extract of and a pharmaceutically acceptable carrier.5. A pharmaceutical or nutraceutical composition comprising the extract of and a pharmaceutically acceptable carrier.6Phyllanthus amarus. A method of making a extract composition comprising a hydrolyzable tannin blend claim 2 , including the steps of:{'i': 'P. amarus', '(a) providing portions of a plant;'}{'i': 'P. amarus', '(b) grinding the plant portions to ...

Подробнее
Номер записи: 16
16-05-2013 дата публикации

Extract of Coptidis Rhizoma and novel use thereof in treating respiratory disease

Номер: US20130122127A1
Автор: Auh Jin, Chang Soo-Im, HAN Chang-Kyun, KIM Chang-Hwan, Shin Min-Ki, Shin Young-June, Yeon Sung-Hum
Принадлежит: AHN-GOOK PHARMACEUTICAL CO., LTD.

A composition for suppressing cough, removing sputum, preventing and/or treating a respiratory disease comprising an extract of Coptidis rhizoma or a combined extract of Coptidis rhizoma with ivy leaf as an active ingredient, and a method of suppressing cough, removing sputum, and/or preventing and/or treating respiratory disease using the composition, are provided. 1. A method of suppressing cough or removing sputum comprising the step of administrating a composition comprising the extract of Coptidis rhizoma as an active ingredient to a patient in need of cough suppression or sputum removal.2. The method according to claim 1 , wherein the composition further comprises an extract of ivy leaf claim 1 , and the composition is administered in the form of a combined extract of Coptidis rhizome and ivy leaf.3. The composition according to claim 2 , wherein the weight ratio of the ivy leaf extract and the Coptidis rhizoma extract is 0.1:1 to 10:1 (the weight of the ivy leaf extract: the weight of the Coptidis rhizoma extract).4. The composition according to claim 3 , wherein the weight ratio of the ivy leaf extract and the Coptidis rhizoma extract is 0.2:1 to 5:1 (the weight of the ivy leaf extract: the weight of the Coptidis rhizoma extract).5. The method according to claim 1 , wherein the dosage of the composition per day is 0.5 to 500 mg/kg claim 1 , based on the amount of the active ingredient.6. The method according to claim 2 , wherein the dosage of the composition per day is 0.5 to 500 mg/kg claim 2 , based on the amount of the active ingredient. This application is a Divisional application of U.S. patent application Ser. No. 12/996,646, which was filed on Dec. 7, 2010, which is a National Stage application of PCT/KR2009/003170 filed on Jun. 12, 2009, which claims priority to Korean Patent Application Nos. 10-2008-0055537 filed on Jun. 13, 2008 10-2008-0055538 filed on Jun. 13, 2008, and 10-2009-0031344 filed on Apr. 10, 2009 the contents of which are incorporated ...

Подробнее
Номер записи: 17
16-05-2013 дата публикации

COMPOSITION COMPRISING AN EXTRACT OF HARDY KIWI FOR PREVENTING OR TREATING BALDNESS DISORDERS OR SEBORRHEIC SKIN DISORDERS

Номер: US20130122128A1
Автор: JIN Mirim, JUNG Hyung-Jin, KIM Bongcheol, KIM Sunyoung, LEE Hwa-Jun
Принадлежит: VIROMED CO., LTD.

Provided is a use of a crude extract, non-polar solvent soluble extract or purified extract of the hardy kiwifruit for the preparation of therapeutic agent for treating and preventing baldness disorder and seborrheic skin disease in human and mammal, and health care food, food additives, feed additives, cosmetic composition comprising the same. The hardy kiwifruit reduced blood DHT level, promoted the formation of hair root in mouse model experiment, and inhibited the falling out of hair and improved seborrheic skin disease of volunteers such as keratigenous skin, seborrhea etc. 1Actinidia arguta. A method for treating or improving seborrheic skin disease or stimulating hair growth comprising administering an effective amount of a lower alcohol extract of fruit to a mammal in need thereof.2. The method according to claim 1 , wherein said extract is administered in a form of a pharmaceutical composition which comprises said extract in an amount ranging from 0.01 to 50% by weight based on the total weight of the formulation and a pharmaceutically acceptable carrier.3. The method of claim 1 , wherein the mammal is human.4Actinidia arguta. The method according to claim 1 , which comprises orally administering a composition comprising the effective amount of said extract of fruit.5Actinidia arguta. The method according to claim 1 , which comprises topically applying a composition comprising the effective amount of said extract of fruit to the surface area which is in need of the treatment claim 1 , of the mammal. This application is a continuation application of U.S. application Ser. No. 12/868,130 (now allowed) filed on Aug. 25, 2010, which is a continuation-in-part application of U.S. application Ser. No. 11/573,445 filed on Feb. 8, 2007, which is a national stage application under 35 U.S.C. §371 of PCT/KR2004/002010 filed on Aug. 10, 2004, the disclosures of which are incorporated herein by reference.1. Technical FieldThe present invention relates to a composition ...

Подробнее
Номер записи: 18
30-05-2013 дата публикации

Compositions and Methods for Pain Reduction

Номер: US20130136811A1
Автор: Schachter Steven C.
Принадлежит: President and Fellows of Harvard College

Compositions containing four-herb extract combination or Wogonin are useful in methods for the reduction of pain. A four-herb combination is used to treat pain as well as reduce or prevent epileptic seizures. 1Scutellaria, Glycyrrhiza, ZiziphusPaeonia,. A pharmaceutical composition comprising a purified compound or processed plant material of a combination of two to four herbs selected from the group consisting of and or extracts thereof.2. The composition of claim 1 , wherein said composition comprises an extract or purified compound of said herbs.3. The composition of claim 1 , further comprising Wogonin.4Scutellaria, Glycyrrhiza, ZiziphusPaeonia,. A method of preventing and reducing pain perception claim 1 , comprising administering to a mammal a composition comprising a combination of two to four herbs selected from the group consisting of and or extracts thereof claim 1 , wherein said composition reduces pain perception by at least 10% compared to the level of pain perception in the absence of said composition.5. The method of claim 4 , wherein said composition comprises an extract or purified compound of each of said herbs.6. The method of claim 4 , further comprising administering Wogonin.7Scutellaria, Glycyrrhiza, ZiziphusPaeonia,. A method of preventing the onset of and reducing the severity of a seizure disorder claim 4 , comprising administering to a mammal a composition comprising a combination of two to four herbs selected from the group consisting of and or extracts thereof claim 4 , wherein said composition prevents the onset of or the severity of a seizure disorder.8. The method of claim 7 , wherein said composition comprises an extract or purified compound of said herbs.9. The method of claim 7 , further comprising administering Wogonin.10. A method of preventing and reducing pain perception claim 7 , comprising administering to a mammal a composition comprising purified Wogonin in an amount sufficient to reduce pain perception by at least 10% ...

Подробнее
Номер записи: 19
30-05-2013 дата публикации

ANTI-INFLAMMATORY COMPOSITIONS

Номер: US20130136813A1
Автор: Arpini Sabrina, Giori Andrea, Togni Stefano
Принадлежит: INDENA S.P.A.

The present invention relates to the use as an anti-inflammatory of tamarind seed polysaccharide (TSP) and to anti-inflammatory compositions which contain it as active ingredient. Anti-inflammatory compositions containing TSP are particularly useful for topical administration in the treatment of inflammatory diseases of the skin and mucosa. 1. Method of treating inflammatory diseases comprising:administering an effecting amount of Tamarind seed polysaccharide for use to a patient in need thereof.2. Method of claim 1 , wherein said inflammatory diseases comprises inflammatory disease of skin or mucosa.3. Method of claim 1 , for topical administration.4. Method of claim 1 , wherein said inflammatory diseases comprise dermatitis claim 1 , mucositis and stomatitis.5. An anti-inflammatory pharmaceutical and/or dermocosmetic composition comprising tamarind seed polysaccharide as active ingredient mixed with one or more acceptable excipients.6. A composition according to claim 5 , for topical administration.7. A composition according to claim 5 , in the form of cream claim 5 , ointment claim 5 , gel claim 5 , lotion claim 5 , gum claim 5 , toothpaste claim 5 , mouthwash or shampoo.8. A composition according to claim 5 , comprising at least a further active ingredient selected from the group consisting of antimicrobial agents claim 5 , anti-inflammatory agents claim 5 , analgesic agents and wound-healing agents.9Aesculus hippocastanum.. A composition according to claim 5 , further comprising an extract of10Helichrysum italicum, FerulaZanthoxylum bungeanum. A composition according to claim 5 , further comprising an extract of spp. claim 5 , or mixtures thereof.11. A composition according to claim 5 , wherein the tamarind seed polysaccharide quantity ranges from 0.1% to 5% by weight.12. (canceled)13. A method of treating a patient having an inflammatory disease comprising administering a therapeutically effective amount of Tamarind seed polysaccharide. The present invention ...

Подробнее
Номер записи: 20
06-06-2013 дата публикации

HEALTH SUPPLEMENT COMPOSITIONS FOR COMPANION ANIMALS AND METHODS OF USING THE SAME

Номер: US20130142894A1
Автор: Al-Murrani Samer
Принадлежит: BIMINI LLC

Aspects of the present invention include compositions configured for maintaining health and/or treating progressive degenerative conditions, e.g., hip and joint conditions, kidney conditions, etc., in companion animals. The compositions include supplement formulations and a highly palatable edible backbone, e.g., in the form of a soft chew, tablet or drink. Supplement formulations of interest include one or more naturally occurring active agents which are effective in maintaining health and/or treating a progressive degenerative condition. Methods of maintaining health of and/or treating a companion animal for a progressive degenerative disease by administering the supplement formulations are also provided. 1. A method of maintaining health and/or treating a progressive degenerative condition in a companion animal , the method comprising:administering to a companion animal a composition comprising:(a) a supplement formulation comprising a health maintenance and/or progressive degenerative condition active agent in an amount effective to maintain health and/or treat the progressive degenerative condition; and(b) a highly palatable backbone;in a manner sufficient to maintain health and/or treat the companion animal for the progressive degenerative condition.2. The method according to claim 1 , wherein the active agent comprises a naturally occurring active agent.3. The method according to claim 2 , wherein the naturally occurring active agent is a plant or derivative thereof.4. The method according to claim 3 , wherein the plant is an herb.5. The method according to claim 1 , wherein the active agent exhibits anti-inflammatory activity.6. The method according to claim 5 , wherein the active agent exhibits anti-inflammatory activity and pain-relief activity.7. The method according to claim 5 , wherein the active agent exhibits anti-inflammatory activity and hypotensive activity.8Rehmannia, Astragalus,. The method according to claim 1 , wherein the supplement ...

Подробнее
Номер записи: 21
13-06-2013 дата публикации

ANTIMICROBIAL COMPOSITIONS

Номер: US20130149257A1
Автор: Giori Andrea, Mombelli Giacomo, Togni Stefano
Принадлежит: INDENA S.P.A.

The present invention relates to the use as an antimicrobial of tamarind seed polysaccharide (TSP) and to antimicrobial compositions which contain it as active ingredient. Antimicrobial compositions containing TSP are particularly useful for topical administration in the treatment and/or prevention of microbial infections of the skin and mucosa. 1. Method of preventing or treating microbial infection comprising:administering and effecting amount of Tamarind seed polysaccharide to a patient in need thereof.2. Method according to claim 1 , wherein the infection is caused by a bacterium claim 1 , a yeast claim 1 , a virus or a fungus.3. Method according to claim 2 , wherein the infection is a bacterial infection.4. Method according to wherein said microbial infections are microbial infections of skin or mucosa.5. Method according to for topical administration.6. Method according to for treating mucositis and stomatitis.7. An antimicrobial pharmaceutical and/or dermocosmetic composition containing tamarind seed polysaccharide as active ingredient mixed with one or more acceptable excipients.8. A composition according to claim 7 , for topical administration.9. A composition according to claim 7 , in the form of cream claim 7 , ointment claim 7 , gel claim 7 , gum claim 7 , toothpaste claim 7 , mouthwash or shampoo.10. A composition according to claim 7 , comprising at least a further active ingredient selected from the group consisting of antimicrobial agents claim 7 , anti-inflammatory agents and wound-healing agents.11Helichrysum italicum, EchinaceaAesculus hippocastanum, Zanthoxylum bungeanum. A composition according to claim 7 , further comprising an extract of spp. claim 7 , or mixtures thereof.12. A composition according to claim 7 , wherein the tamarind seed polysaccharide quantity ranges from 0.1% to 5% by weight.13. (canceled)14. A method of preventing and/or treating a patient having a microbial infection comprising administering a therapeutically effective ...

Подробнее
Номер записи: 22
13-06-2013 дата публикации

Herbal composition for preventing and/or treating anxiety related conditions

Номер: US20130149370A1
Автор: Nadav Kately, Ravid Doron
Принадлежит: OPMOP Ltd

The present invention relates to herbal compositions for the treatment and/or prevention of anxiety disorders or stress. These compositions comprise hawthorn fruit (Shan Zha), light wheat grain (Fu xiao mai) and Lilly Bulb (bai hi) in amounts which are effective to treat anxiety conditions. The compositions may further comprise Chinese date (Da zao).

Подробнее
Номер записи: 23
13-06-2013 дата публикации

COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF

Номер: US20130149398A1
Автор: Alex Philip, Centola Michael, Payne Adam Joshua, YESUDAS Tomy
Принадлежит: HAUS BIOCEUTICALS, INC.

Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient. 1. A composition comprising a mixture of plant extracts , wherein the mixture comprises:a) at least one Group I plant extract and at least one Group II plant extract, wherein the at least one Group I plant extract and the at least one Group II plant extract are different;b) at least one Group I plant extract and at least one Group III plant extract, wherein the at least one Group I plant extract and the at least one Group III plant extract are different;c) at least one Group I plant extract and at least one Group IV plant extracts, wherein the at least one Group I plant extract and the at least one Group IV plant extract are different;d) at least one Group II plant extract and at least one Group III plant extracts, wherein the at least one Group II plant extract and the at least one Group III plant extract are different;e) at least one Group II plant extract and at least one Group IV plant extract, wherein the at least one Group II plant extract and the at least one Group IV plant extract are different;f) at least one Group III plant extract and at least one Group IV plant extract, wherein the at least one Group III plant extract and the at least one Group IV plant extract are different;g) at least one Group I plant extract, at least one Group II plant extract, and at least one Group III plant extract, wherein the at least one Group I plant extract, the at least one Group II plant extract, and the at least one Group III plant extract are different;h) at least one Group I plant extract, at least one Group II plant extract, and at least one Group IV plant extract, wherein the at least one Group I plant extract, the at least one Group II plant extract, and the at least one Group IV plant extract are different;i) at least one Group I plant extract, at ...

Подробнее
Номер записи: 24
13-06-2013 дата публикации

Method for treating hepatitis c

Номер: US20130150435A1
Автор: Cheng Lin, Lain-tze Lee, Shao-Chan Yin, Shau-Feng Chang, Shu-Jiau Chiou
Принадлежит: Industrial Technology Research Institute ITRI

The disclosure provides a method for treating hepatitis C, including: administering an effective amount of a proanthocyanidins oligomer to a subject in need, wherein the structure of the proanthocyanidins oligomer is shown as Formula (I): and in Formula (I), N is an integer of about 1-18.

Подробнее
Номер записи: 25
20-06-2013 дата публикации

METHODS AND COMPOSITIONS FOR TREATING DISTRESS DYSFUNCTION AND ENHANCING SAFETY AND EFFICACY OF SPECIFIC MEDICATIONS

Номер: US20130156874A1
Автор: Crain Michael, Crain Stanley M., Crain Steven, Crain William E.
Принадлежит: Pondera Biotechnologies, LLC

The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one Receptor Switcher and at least one Endorphin Enhancer. Additionally, at least one Synergistic Enhance and/or at least one Exogenous Opioid are also administered to enhance or prolong the therapeutic effects. 141.-. (canceled)42. A method to safely and effectively treat a respiratory disease or symptoms associated with a respiratory disease in a subject in need comprising:(a) administering at least one Receptor Switcher to the subject; and(b) administering at least one compound to the subject selected from the group consisting of an Endorphin Enhancer, an Exogenous Opioid, a Synergistic Enhancer, and any combination thereof.43. The method of claim 42 , wherein the respiratory disease and/or symptoms are selected from the group consisting of asthma claim 42 , chronic obstructive pulmonary disease (COPD) claim 42 , and neonatal apnea.44. The method of claim 42 , wherein the method results in improving respiration.45. The method of claim 42 , wherein the combination of the Receptor Switcher with one or more of an Endorphin Enhancer claim 42 , an Exogenous Opioid claim 42 , and a Synergistic Enhancer results in a decrease in side effects associated with administration of the compounds alone.46. The method of claim 42 , wherein the Receptor Switcher:(a) when co-administered with an Endorphin Enhancer, an Exogenous Opioid, and/or a Synergistic Enhancer, reduces and/or resolves one or more respiratory disease symptoms; and(b) is selected from the group consisting of agents that selectively block and/or inhibit opioid receptor excitatory signaling, ultra-low-dose, very-low-dose and low dose opioid antagonists, ultra-low-dose and very-low-dose naltrexone, naloxone, diprenorphine, nalmefene, and norbinaltorphimine, agents that inhibit synthesis or activity of GM1 ganglioside, ...

Подробнее
Номер записи: 26
27-06-2013 дата публикации

COMPOSITION CONTAINING PRUNUS MUME EXTRACT FOR EXTERNAL APPLICATION TO SKIN

Номер: US20130164391A1
Автор: Kim Hyuk, KIM Jeong Hwan, Koh Hyun Ju, Park Won Seok, Shin Hong Ju
Принадлежит:

The present disclosure provides a composition for external application to the skin for skin care after laser treatment, which contains extract as an active ingredient. The composition for external application to the skin according to the present disclosure has skin-soothing, skin barrier-recovering and pain-relieving effects and, therefore, can be developed into a cosmetic composition having additional effects of protecting sensitive skin, preventing skin sensitivity, providing skin stability and moisturizing the skin. 1Prunus mume. A method for aftercaring a skin after laser treatment to the skin in a subject , comprising transdermally administering an effective amount of extract to the subject.2Prunus mume. The method according to claim 1 , wherein the extract soothing soothes the skin claim 1 , relieves skin pain or recovers the skin barrier.3Prunus mumePrunus mume. The method according to claim 1 , wherein the extract is administered in a form of a composition comprising 0.001-10 wt % of the extract based on the total weight of the composition.4. (canceled)5Prunus mume. The method according to claim 1 , wherein the extract protects sensitive skin claim 1 , prevents skin sensitivity claim 1 , provides skin stability and moisturizes the skin after laser treatment.6. The method according to claim 3 , wherein the composition is in the form selected from a group consisting of solution claim 3 , suspension claim 3 , emulsion claim 3 , paste claim 3 , gel claim 3 , lotion claim 3 , cream claim 3 , essence claim 3 , pack claim 3 , soothing mask claim 3 , topical patch claim 3 , makeup base claim 3 , moisturizing oil claim 3 , powder claim 3 , soap claim 3 , surfactant-containing cleanser claim 3 , oil claim 3 , powder foundation claim 3 , emulsion foundation claim 3 , wax foundation claim 3 , oil-in-water (O/W) or water-in-oil (W/O) emulsion and spray. The present disclosure relates to a composition containing Prunus mume extract for external application to the skin. ...

Подробнее
Номер записи: 27
27-06-2013 дата публикации

COMPOSITION FOR IMPROVING SEXUAL WELLNESS

Номер: US20130164394A1
Автор: Burki Carolina, Ferrari Victor, Schönlau Frank
Принадлежит: HORPHAG RESEARCH (IP) PRE LTD.

The invention relates to improving sexual fitness or wellness of both sexes, the male sexual enhancement, the treatment of sexual dysfunction and the health of the sexual vascular system of both sexes with ingredients that consist in a source of proanthocyanidins, a source of arginine, rose hip extracts and/or extracts. The source of proanthocyanidins may be a botanical extract and the source of arginine may be from arginine aspartate. 1. A preparation consisting in a combination of:a source of proanthocyanidins,a source of arginine,{'i': 'Quercus robur', 'Rose hip and/or extracts thereof or and/or extracts thereof or a mixture thereof, and a suitable excipient.'}2. The preparation according to claim 1 , wherein said source of arginine is arginine or citrulline or ornithine or any arginine precursors or derivatives thereof.3. The preparation of or claim 1 , wherein said source of arginine is a salt or dipeptide of L-arginine and aspartic acid.4. The preparation of to claim 1 , wherein said source of proanthocyanidins is originated from a plant extract or from a synthesized material.5. The preparation of claim 4 , wherein the plant extract is selected from the group consisting of proanthocyanidins containing extracts selected among extracts of pine bark claim 4 , grape seed claim 4 , apples claim 4 , peanut skin claim 4 , walnuts claim 4 , pomegranates claim 4 , raspberry claim 4 , currants (black) claim 4 , blueberry claim 4 , almonds claim 4 , tea claim 4 , hawthorn claim 4 , cocoa or combination thereof.6. The preparation of claim 5 , wherein the plant extract is originated from pine bark claim 5 , preferably the French maritime pine bark.7. The preparation of any of to claim 5 , wherein Rose hip and/or extracts thereof comprise carotenoids claim 5 , tocopherols claim 5 , tocotrienols claim 5 , vitamin C claim 5 , polyphenols and glycosides of mono- or di- or triacylglycerol compounds.8. The preparation of any of to claim 5 , wherein the suitable excipient is a ...

Подробнее
Номер записи: 28
04-07-2013 дата публикации

EXTRACT OF THE ABOVE-GROUND PORTIONS OF GYNANDROPSIS GYNANDRA OR CLEOME GYNANDRA, AND COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS INCLUDING SAME

Номер: US20130171082A1
Автор: Baudouin Caroline, Debrock Sebastien, Leclere-Bienfait Sophie, Msika Philippe, Saunois Alex
Принадлежит: LABORATOIRES EXPANSCIENCE

The invention relates to a composition, such as a cosmetic, dermatological, or pharmaceutical composition, including an extract of the above-ground portions of , advantageously the leaves and, optionally, a suitable carrier. The invention also relates to such a composition or such an extract to be used in the prevention or treatment of disorders or diseases of the skin, mucous membranes, or nails and hair, to be used in the prevention or treatment of vascular disorders and/or problems linked to hyperseborrhea, or further to be used as an anti-ageing, healing, moisturising, slimming and/or anti-cellulite, anti-allergy and pro-pigmenting product. Finally, the invention relates to a cosmetic care method for the skin, nails and hair, or mucous membranes, with a view to improving the condition or appearance thereof, consisting of administering such a composition or such an extract. 1Gynandropsis gynandra. A composition including as active ingredient an extract of the above-ground parts of , characterized in that the extract includes at least 3% polyphenols by weight , expressed in gallic acid equivalents in relation to the weight of the dry extract , said polyphenols being advantageously flavonoids , typically at a concentration of at least 1% flavonoids by weight , expressed in rutin equivalents in relation to the weight of the dry extract , and if need be a suitable carrier.2. The composition of claim 1 , characterized in that the composition is intended to be applied by topical external route to the skin claim 1 , keratinous appendages and/or mucous membranes claim 1 , in particular skin claim 1 , keratinous appendages and/or mucous membranes that are sensitive or damaged by the environment.3Gynandropsis gynandra. The composition of or claim 1 , characterized in that the extract is an extract of leaves.4Gynandropsis gynandra. The composition of any one of the preceding claims claim 1 , characterized in that the extract is obtained by solid-liquid extraction of the ...

Подробнее
Номер записи: 29
04-07-2013 дата публикации

Composition Comprising Cudrania Tricuspidata and Coix Lachryma-Jobi for Suppressing Obesity or Lowering Blood Sugar, and Use Thereof

Номер: US20130171276A1
Автор: Do Jeong Ryong, Han Chan Kyu, Kim Hyun Ku
Принадлежит: KOREA FOOD RESEARCH INSTITUTE

The present invention relates to a pharmaceutical composition for suppressing obesity or lowering blood sugar which comprises extract and -extract, and more specifically relates to a pharmaceutical composition for suppressing obesity or lowering blood sugar which comprises extract and extract, to a functional health food or food additive composition for suppressing obesity or lowering blood sugar which comprises extract and -extract, to a tablet having an obesity-suppressing function and blood-sugar lowering effect which is produced using and - 17-. (canceled)8. A method for preparing a tablet for suppressing obesity or lowering blood sugar , comprising the steps of:{'i': Cudrania tricuspidata', 'Coix lachryma', 'jobi', 'Dioscorea Rhizome', 'Morus alba', 'Hovenia dulcis, Glycyrrhiza uralensis', 'Rubus coreanus Miguel', 'Cnidium', 'Lycium', 'Schizandra', 'Astragalus', 'Cudrania tricuspidata', 'Coix lachryma', 'jobi, '(a) mixing extract and -extract with 10-50 parts by weight of one or more herbal medicines selected from the group consisting of red ginseng, ginseng, , the leaf of , the fruit, stem, and leaf of , cinnamon bark, Golden thread, , Dodder seed, fruit, fruit, fruit and root, based on 100 parts by weight of extract and -extract so as to prepare a mixture;'}{'i': Cudrania tricuspidata', 'Coix lachryma', 'jobi', 'Cudrania tricuspidata, Coix lachryma', 'jobi, herbal medicines, and functional substances;, '(b) adding to the mixture one or more functional ingredients selected from the group consisting of 1-5 parts by weight of vitamin, 1-10 parts by weight of saccharide, 0.5-5 parts by weight of squalene, 0.5-5 parts by weight of taurine, 1-10 parts by weight of herb, 0.1-5 parts by weight of octacosanol and 1-5 parts by weight of sodium alginate, based on 100 parts by weight of extract and -extract, and mixing them so as to prepare a mixture of -'}(c) ripening the mixture at 5-20° C. for 10-20 hours;(d) preparing tablets using a tabletting machine; and(e) ...

Подробнее
Номер записи: 30
04-07-2013 дата публикации

COMPOSITION FOR PROMOTING MEMORY AND LEARNING ABILITY

Номер: US20130171278A1
Автор: Cho Sueong-Mock, Choi Jun-Hyeok, Han Dae Seok, Kim In-ho, Kim Young-Eon, Lee Chang-Ho, Lee Hye-Sung, Park Dong-Jun
Принадлежит: KOREA FOOD RESEARCH INSTITUTE

The present invention relates to a composition for promoting memory or learning ability and to a composition for preventing and treating cognitive impairment, which comprise one, two or more plant extracts selected from the group consisting of extract, extract and extract. The present invention has the effect of inhibiting neural cell damage, especially, neural cells of the basal part of the cerebrum by inhibiting acetylcholinesterase activity and through antioxidative activity (for example, inhibiting the generation of oxidative reactive species) and affinity for an NMDA receptor. The compositions of the present invention may have the effect of not only promoting memory or learning ability by protecting neural cells and preventing damage to neural cells but also of preventing and treating diseases caused by cognitive impairment. In addition, according to the present invention, extract is provided as basic substance for pharmaceuticals or food which has efficacy in promoting memory or learning ability or efficacy for preventing and treating cognitive impairment. 19-. (canceled)10Artemisia apiaceaeIllicium verumLepidium apefalum.. A method for enhancing memory and learning ability , comprising administering to a subject in need thereof a composition comprising a plant extract as an active ingredient; wherein the plant extract is one or more selected from the group consisting of an extract of , an extract of and an extract of11Artemisia apiaceaeIllicium verumLepidium apefalum.. A method for preventing or treating cognitive disorders , comprising administering to a subject in need thereof a composition comprising a plant extract as an active ingredient; wherein the plant extract is one or more selected from the group consisting of an extract of , an extract of and an extract of12. The method according to claim 10 , wherein the composition inhibits an activity of acetylcholinesterase.13. The method according to claim 10 , wherein the composition has an antioxidant ...

Подробнее
Номер записи: 31
04-07-2013 дата публикации

Neuroprotective Natural Extract from Passion Fruit

Номер: US20130171284A1
Автор: Artan Avital, Goldenberg Livnat, Pesis Edna, Samach Alon, Tirosh Oren, Troen Aron
Принадлежит:

Methods for the treatment and prevention of neural cell and neuro-pathological disorders are provided, comprising contacting the neural cells, or administering to a subject in need thereof, botanical raw material (BRM) or an extract obtainable from passion fruits. Compositions, as well as a nutraceutical composition comprising the same are also provided. 1. A method for protection from , reduction , prevention or inhibition of neural cell damage or deterioration in neural cell function , said method comprising the step of contacting said neural cell with a botanical raw material (BRM) or an extract obtainable from passion fruits.2. The method according to claim 1 , for protection from claim 1 , reduction claim 1 , prevention or inhibition of neural cell damage or deterioration in neural cell function in a subject suffering from a neuro-pathological condition claim 1 , said method comprising the step of administering to said subject an effective amount of a botanical raw material (BRM) or an extract obtainable from passion fruits.3. (canceled)4. The method according to claim 1 , wherein said passion fruits are of at least one of a cultivar designated 428 and a cultivar designated Passion Dream (PD) claim 1 , or any crosses or progeny thereof.5. (canceled)6. The method according to claim 1 , wherein said BRM or an extract obtainable from passion fruits is any one of a juice claim 1 , fruit skin claim 1 , pulp or seeds obtained from at least one variety or cultivar of passion fruits or a mixture of two or more cultivars of passion fruits claim 1 , or any concentrate or preparation obtained from said juice claim 1 , fruit skin claim 1 , pulp claim 1 , seeds or fruits.7. The method according to claim 1 , wherein said BRM or extract obtainable from passion fruits reduces at least one of radical cellular oxygen species (ROS) levels claim 1 , oxygen species toxicity and glutamate toxicity.8. A method for the treatment claim 1 , prophylaxis claim 1 , amelioration claim 1 , ...

Подробнее
Номер записи: 32
18-07-2013 дата публикации

COSMETIC OR DERMATOLOGICAL COMPOSITION FOR TOPICAL APPLICATION

Номер: US20130183394A1
Автор: Wuttke Wolfgang
Принадлежит: BIONORICA AG

The invention relates to a cosmetic or dermatological composition, preferably purely plant-based, for topical use, containing as the primary natural active ingredient, and to the use thereof for the prophylaxis and the treatment of skin diseases, in particular acne, seborrhea, atopic eczema (neurodermatitis), hirsutism, psoriasis, and dry/atopic skin of humans. 1Cimicifuga. A cosmetic or dermatological composition for topical use , comprising as the primary active ingredient 1.0 to 50% by weight for the prophylaxis and treatment of skin diseases , particularly acne , seborrhea , atopic eczema (neurodermatitis) , hirsutism , psoriasis and dry/atopic skin of humans , and further auxiliary agents and/or additives.2Cimicifuga.. The cosmetic or dermatological composition for topical use according to claim 1 , wherein it comprises 2.0 to 30% by weight of3Calendula.. The cosmetic or dermatological composition for topical use according to claim 1 , additionally comprising extracts of soy claim 1 , red clover claim 1 , hops claim 1 , grape skins and4. The cosmetic or dermatological composition for topical use according to claim 1 , wherein it contains 0.1 to 15% by weight of unsaponifiable constituents of at least one further vegetable oil.5. The cosmetic or dermatological composition for topical use according to claim 1 , in the form of a cream claim 1 , gel claim 1 , lotion claim 1 , paste claim 1 , ointment claim 1 , skin oil claim 1 , or emulsion.6. The cosmetic or dermatological composition for topical use according to claim 1 , wherein it comprises at least one further vegetable oil claim 1 , which includes at least 6% by weight of polyunsaturated fatty acids claim 1 , as an additive.7. The cosmetic or dermatological composition for topical use according to claim 1 , wherein it comprises one or more additives selected from the group consisting of jojoba oil claim 1 , olive oil claim 1 , sunflower oil claim 1 , soy bean oil claim 1 , peanut oil claim 1 , rapeseed oil ...

Подробнее
Номер записи: 33
18-07-2013 дата публикации

COMPOSITIONS COMPRISING BOTANICALS, INCLUDING THE USE AND METHOD OF USE THEREOF

Номер: US20130183395A1
Автор: Coventry Krista
Принадлежит: Fem Med Formulas Limited Partnership

A composition comprising indole-3-carbinol, milk thistle, schizandra, stinging nettle, hydroxymatairesinol ligands and optionally calcium-d-glucarate and 400 KJ Vitamin D for altering urinary estrone metabolite and preventing breast cancer in pre and post menopausal women 1. A composition comprising: Indole-3-Carbinol; Milk Thistle; Schizandra; Stinging Nettle; and Hydroxymatairesinol Lignans.2. The composition of further comprising Vitamin D (Chloecalciferol [Vitamin D3]).3. The composition of further comprising Calcium-D-Glucarate.4. The composition according to comprising:about 200 mg of Indole-3-Carbinol;{'i': 'Silybum marianum', 'about 100 mg of Milk Thistle (seed extract, 2:1);'}{'i': 'Schisandra chinensis', 'about 75 mg of Schizandra (fruit extract, 4:1);'}{'i': 'Urtica dioica', 'about 50 mg of Stinging Nettle (leaf extract, 4:1); and'}{'i': 'Picea abies', 'about 10 mg of Hydroxymatairesinol Lignans ([Norway Spruce]).'}5. The composition according to further comprising about 400 IU/10 mcg of Vitamin D (Cholecalciferol [Vitamin D3]).6. The composition according to further comprising about 75 mg of Calcium-D-Glucarate.7. A composition consisting of: Indole-3-Carbinol; Milk Thistle; Schizandra; Stinging Nettle; and Hydroxymatairesinol Lignans.8. The composition according to consisting of:about 200 mg of Indole-3-Carbinol;{'i': 'Silybum marianum', 'about 100 mg of Milk Thistle (seed extract, 2:1);'}{'i': 'Schisandra chinensis', 'about 75 mg of Schizandra (fruit extract, 4:1);'}{'i': 'Urtica dioica', 'about 50 mg of Stinging Nettle (leaf extract, 4:1); and'}{'i': 'Picea abies', 'about 10 mg of Hydroxymatairesinol Lignans ([Norway Spruce]).'}10. The composition of further comprising cellulose claim 9 , water claim 9 , microcrystalline cellulose claim 9 , and magnesium stearate as non-medicinal ingredients.1120.-. (canceled)21. A method for altering urinary estrone metabolite levels in a woman claim 1 , comprising administering to said woman a therapeutically ...

Подробнее
Номер записи: 34
25-07-2013 дата публикации

Method of Altering Perception of Time

Номер: US20130189378A1
Автор: Hirsch Alan R.
Принадлежит:

Methods and compositions for modifying an individual's perception of an interval of time are disclosed. 1. A method of modifying a person's defective or impaired time processing , comprising administering to the person by inhalation an effective amount of a composition comprising a coffee odorant such that the person's estimate of the length of a time interval is shorter than the person's estimate of the same time interval made without inhalation of the composition.2. The method of claim 1 , wherein the composition consists essentially of the coffee odorant in a carrier claim 1 , and optional additives.3. The method of claim 1 , wherein the composition comprises a mixture of the coffee odorant with at least one of a peppermint odorant or a vanilla odorant as a secondary odorant that complements and does not mask the coffee odorant.4. The method of claim 3 , wherein the composition comprises a suprathreshold and non-irritant concentration of the coffee odorant and a less than suprathreshold concentration of the secondary odorant.5. A method of modifying a person's defective or impaired time processing claim 3 , comprising administering to the person by inhalation an effective amount of a composition comprising a baby powder odorant such that the person's estimate of the length of a time interval is longer than the person's estimate of the same time interval made without inhalation of the composition.6. The method of claim 6 , wherein the composition consists essentially of the baby powder odorant in a carrier claim 6 , and optional additives.7. The method of claim 1 , wherein the composition comprises a mixture of the baby powder odorant with a vanilla odorant as a secondary odorant that complements and does not mask the baby powder odorant.8. The method of claim 7 , wherein the composition comprises a suprathreshold and non-irritant concentration of the baby powder odorant and a less than suprathreshold concentration of the vanilla odorant.9. A method of treating a ...

Подробнее
Номер записи: 35
15-08-2013 дата публикации

Optimized Extraction Process for Obtaining Labisia Pumila Extract

Номер: US20130209594A1
Автор: Che Ani Noridayu, Gantala Venkatesh, Ho Miau Ching, Navaratnam Visweswaran, Zulkarnaini Defri bin
Принадлежит: Pharmaniaga Bhd

The present invention relates to a process for obtaining a water extract comprising the steps of: obtaining an extract from dried plant material using water extraction, filtering the extract to obtain filtrate and plant material residue, re-extracting the residue using water extraction, centrifuging the extracts to obtain a supernatant, characterized in that, the plant material includes leaves and roots in a ratio of 3:2 by weight and ratio of the dried plant material to water used in the water extraction process is 1:10 by weight, wherein the yield obtained from initial extraction is 7% to 8% and the extra yield obtained from re-extraction is 33% to 38% and the total yield obtained from the extraction is 10% to 12%. 1Labisia pumila. A process for obtaining a extract comprising the steps of:{'i': 'Labisia pumila', 'obtaining an extract from dried plant material using water extraction;'}{'i': 'Labisia pumila', 'filtering the extract to obtain filtrate and plant material residue;'}{'i': 'Labisia pumila', 're-extracting the residue using water extraction;'}{'i': 'Labisia pumila', 'centrifuging the extracts to obtain a supernatant;'}{'i': 'Labisia pumila', 'characterized in that, the plant material includes leaves and roots in a ratio of 3:2 by weight and ratio of the dried plant material to water used in the water extraction process is 1:10 by weight.'}2Labisia pumila. The process according to claim 1 , wherein the dried plant material is extracted through water extraction using distilled water or reverse osmosis water or deionised water.3. The process according to claim 1 , wherein the water extraction is performed at temperature of 80° C. for 3 hours with stirring.4Labisia pumila. The process according to claim 1 , wherein the filtered residue is re-extracted using water extraction at temperature of 80° C. for an hour.5. The process according to claim 1 , wherein the centrifuging is conducted at 3500 rpm for 15 minutes.6. The process according to claim 1 , wherein ...

Подробнее
Номер записи: 36
29-08-2013 дата публикации

COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS INCLUDING GALENICAL EXTRACT OR LACTOBACILLUS FERMENTATION THEREOF

Номер: US20130224181A1
Автор: Cho Byoung Heon, Choi Sung Up, CHUNG Tae Ho, Eum Hyun Ae, Im Ga Young, Kim Dong Seon, LEE Jae Hoon, MA Jin Yeul, UM Young Ran
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a pharmaceutical composition and health supplement for preventing or treating atopic dermatitis, the composition and supplement having as active ingredients extract of a galenical mixture including sophora root, licorice, lonicer aflower, Korean angelica root, Korean aralia root, saussurea root, seselos radix, zizyphus spinosi, Houttuynia cordata, forsythia fruit, lappa fruit, Epimedium koreanum Nakai, ginseng, lithospermum, oleoresin, cnidium, scorophulariae radix, and reynoutria, or lactobacillus fermentation of the galenical extract prepared by inoculating lactobacillus to the galenical extract and fermenting same. The galenical extract or the galenical extract fermentation of the present invention achieves reduced scratching, decreases clinical features of atopic symptoms such as erythema, itchiness and dry skin, edema and hematoma, erosion, and lichenification, and reduces IgE concentration in blood, which is related to exogenous atopic dermatitis, in laboratory animal models of atopic dermatitis, and is thereby, useful for preventing or treating atopic dermatitis. 1. A herb extract prepared by extracting a herb mixture comprising Sophora flavescens , Licorice (Glycyrrhiza uralensis) , Lonicera jabonica , Angelica gigas , Aralia continentalis , Saussurea lappa , Bangpoong (Saposhnikovia divaricata) , Zizyphus jujuba , Houttuynia cordata , Forsythia koreana , Arctii Fructus , Epimedium koreanum , Ginseng , Lithospermi Radix , Sanguisorbae officinalis , Cnidium officinale , Scrophularia buergeriana , and Reynoutria elliptica by using water or an organic solvent.2. The herb extract according to claim 1 , wherein the herb extract is extracted by hot-water extraction from the herb mixture comprising 10 weight parts of Sophora flavescens claim 1 , 2˜8 weight parts of Licorice (Glycyrrhiza uralensis) claim 1 , 2˜8 weight parts of Lonicera jabonica claim 1 , 2˜8 weight parts of Angelica gigas claim 1 , 2˜8 weight parts of Aralia ...

Подробнее
Номер записи: 37
05-09-2013 дата публикации

METHODS OF IMPROVING MENTAL OR PHYSICAL HEALTH CONDITIONS IN AN INDIVIDUAL

Номер: US20130230608A1
Автор: Schmitt Jeroen Antonius Johannes, Silber Yvonne Beata
Принадлежит: NESTEC S.A.

Methods of improving mental or physical health conditions of an individual are provided. In a general embodiment, the method provides administering to an individual in need of an improved mental or physical health condition a decaffeinated coffee product comprising an unroasted coffee. The mental or physical health condition can be, for example, sustained attention in the individual, improvement in the individual's mood or alertness, reduced headaches in the individual, and/or improved relaxation in the individual.

Подробнее
Номер записи: 38
12-09-2013 дата публикации

SYSTEMS AND METHODS FOR TREATING FIBROMYALGIA

Номер: US20130236572A1
Автор: Kingsley Joe D.
Принадлежит:

A solution and method for treating symptoms commonly associated with fibromyalgia. The solution includes a solvent and a composition including active ingredients of menthol, camphor, and capsaicin, as well as additional components including aloe vera extract, carbomer, decyl polyglucose, deionized water, grapefruit seed extract, green tea extract, orange peel extract, queen of the prairie extract, rose water, silica, sodium, hydroxymethyl glycinate, vegetable glycerin, witch hazel, and yucca extract. The method includes soaking an affected area in the solution for a predetermined period of time. 1. A method of administering a composition for relieving symptoms associated with fibromyalgia of a patient having such symptoms , the method comprising:(i) providing a composition including menthol at about 0.5% v/v to about 10% v/v, camphor at about 0.5% v/v to about 10% v/v, capsaicin at about 0.005% v/v to about 0.1% v/v, and therapeutic amounts of aloe vera extract, carbomer, decyl polyglucose, a grapefruit seed extract, an orange peel extract, a green tea extract, a queen of the prairie extract, rose water, a hydroxymethyl glycinate, a glycerin, witch hazel, and yucca extract;(ii) diluting the composition in a solvent to provide a solution having a desired volume percent of the composition; and(iii) soaking an affected area of the patient in the solution for a desired period of time.2. The method of claim 1 , further comprising repeating step (iii).3. The method of claim 2 , wherein step (iii) is repeated up to three times within a twenty-four hour period.4. The method of claim 2 , wherein step (iii) is repeated at an hourly interval.5. The method of claim 2 , wherein step (iii) is repeated as needed to relieve the symptoms.6. The method of claim 1 , wherein the amount of menthol is about 3% v/v of the composition.7. The method of claim 1 , wherein the amount of camphor is about 3% v/v of the composition.8. The method of claim 1 , wherein the amount of capsaicin is ...

Подробнее
Номер записи: 39
12-09-2013 дата публикации

PROCESS FOR PYGEUM EXTRACTION

Номер: US20130236574A1
Автор: Sharma Ashok, Tewari Kiran
Принадлежит:

An improved process for the extraction of from the plant of the family rosacaea, amygdales tribe, genus species () and related species (as herein defined) comprising the steps of collecting the plant material i.e. stem cuttings/twigs, removing the leaves and drying till moisture content is about 10-15%, powdering the stem material, extracting with chlorinated organic solvents and water-alcohol mixture, in ratio of 1:4, filtering and drying the extract under vacuum at 30 degree Celsius to obtain a greenish mass with bitter almond smell, the mass being referred to as ‘’ wherein in the improved process, a ‘renewable plant source’ i.e. stem cuttings/twigs, are used for extraction of instead of a ‘non-renewable’ source such as bark of the tree. The obtained by the new process has a pharmacopeia profile similar to the product ‘’ obtained from a ‘non-renewable source’ i.e. bark of . Further, it is non-toxic and shows anti-BPH (benign prostatic hyperplasia) activity comparable with that of obtained from non-renewable source i.e. bark of 19-. (canceled)10pygeumPrunus domesticaIndian prunus. A commercially viable process using biowaste for the extraction of from () comprising the steps of:{'i': 'Prunus domestica;', 'collecting ‘bio-waste’ in the form of stem cuttings/twigs with leaves removed, obtained during routine ‘pruning’ or trimming process of'}drying the bio-waste till moisture content is about 10-15%;powdering the same by pulverization;extracting the powdered stem material with chlorinated organic solvents or water-alcohol mixture, in ratio of 1:4 at 35-40° C.; and{'i': 'pygeum', 'filtering and drying the extract under vacuum at 30° C. to obtain ‘’ as a greenish mass with bitter almond smell and in which concentration of total sterols typically calculated as beta-sitosterol, is 15-18% and same has anti-BPH activity.'}11. The process of wherein the chlorinated organic solvents used in the extraction process are methylene dichloride (MDC) or chloroform.12. The process ...

Подробнее
Номер записи: 40
19-09-2013 дата публикации

BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR PREVENTING CARDIOVASCULAR DISEASES AND REINFORCING THE CARDIOVASCULAR SYSTEM

Номер: US20130243881A1
Автор: Elistratov Dmitriy G.
Принадлежит:

The biologically active food additive comprises hawthorn flowers and/or berries and/or leaves and royal jelly in the following ingredient ratio: from 10 mass % to 90 mass % of hawthorn; from 10 to 24 mass % of royal jelly; and from 0 mass % to 70 mass % of fillers. The additive is produced in powder, tablet or capsule form, or aqueous-alcoholic extract form. The complex system of biologically active substances contained in the proposed biologically active food additive not only exerts an effect on the entire cardiovascular system, but also reduces the causes of cardiovascular diseases and improves quality of life in old age by acting on the pathology of the human body. This long-acting agent for prophylaxis and planned health improvement has no contraindications or side effects even during long-term use (more than one year). 1. A biologically active food additive for preventing cardiovascular diseases and enhancing the cardiovascular system comprises hawthorn flowers and/or berries and/or leaves , royal jelly and excipient in a following ratio of the ingredients:hawthorn flowers and/or berries and/or leaves: from 61 to 90 wt. %,royal jelly: from 10 to 24 wt. %,excipients: from 0 to 29 wt. %.2. The biologically active food additive as claimed in claim 1 , wherein the additive is made in a powder form.3. The biologically active food additive as claimed in claim 1 , wherein the additive is made in a capsulated form.4. The biologically active food additive as claimed in claim 1 , wherein the additive is made in a tableted form.5. The biologically active food additive as claimed in claim 1 , wherein the additive is made in an aqueous alcoholic extract form. This application is a U.S. National phase application of the International application WO 2011/078736 A1 (PCT/RU2010/000704) and claims priority to application 2009144334 filed on Nov. 30, 2009 in the Russian Federation, both applications being hereby incorporated by reference in their entirety.1. Field of the ...

Подробнее
Номер записи: 41
26-09-2013 дата публикации

Compositions and methods for treatment of mammalian skin

Номер: US20130251825A1
Автор: Berry Don Wayne
Принадлежит:

Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure. In other embodiments, administration of compositions provided is by injection. Some embodiments provide for preventive use of compositions provided towards preventing some forms of skin cancer and skin cancer-related disorders by repeated application to healthy-looking skin. Methods for providing the compositions are disclosed. 1hamelia patens. A method for alleviating signs of radiation dermatitis induced by clinical exposure to external beam irradiation on the skin of a mammalian subject , which method comprises contacting a composition containing a extract to an affected skin area of said subject in an effective amount and frequency for reducing said symptoms.2. The method according to claim 1 , wherein said composition is in any form selected from the group consisting of: salves claim 1 , creams claim 1 , ointments claim 1 , and lotions.3. The method according to wherein said composition comprises any carrier selected from the group consisting of: water; saline solution claim 1 , any C1 to C4 alcohol; any glyceryl ester oil; and any mineral oil.4. The method according to wherein said composition comprises a pharmaceutically-acceptable carrier.5. The method according to wherein said extract is an aqueous extract.6. The method according to wherein said extract is a non-aqueous extract.7. The method according to wherein said composition comprises a nanoparticle.8. The method according to wherein said nanoparticle is selected from the group consisting of solid core nanoparticles claim 7 , hollow core nanoparticles claim 7 , lipid nanoparticles claim 7 , PEG nanoparticles claim 7 , and chitosan nanoparticles ...

Подробнее
Номер записи: 42
03-10-2013 дата публикации

Food recipes for nourishing, maintaining and cultivating a variety of stem cells and a method for manufacturing the same

Номер: US20130259893A1
Автор: Chi-Ming Wu, Ming-Chia Weng
Принадлежит: WRITER OF RESVERATROL BIOTECH R&D CO Ltd

A food recipes for nourishing, maintaining and cultivating a variety of stem cells, each unit of the food recipes includes grape skin/polygonum cuspidatum root extracts; pseudo-ginseng extracts; cooked polygonum multiflorum thunb extracts; salvia miltiorrhiza bunge extracts; blueberry extracts; bitter melon extracts; soybean extracts; ginseng extracts; rhodiola extracts; yam extracts; licorice extracts; kudzu extracts; brown algae extracts; green algae extracts; szechuan lovage rhizome extracts, Green tea extracts; apple extracts; leek seed extracts; wolfberry extracts; marigold extracts; ganoderma lucidum extracts; caterpillar fungus extracts; agaricus blazei extracts; cistanche deserticola extracts; mushroom extracts; beer yeast; flaxseed oil powder; and vitamin.

Подробнее
Номер записи: 43
03-10-2013 дата публикации

METHOD FOR PREPARING SUPPLEMENT USING PETTITOES OR PIG'S HEAD AND ZANTHOXYLUM PIPERITUM, AND COMPOSITION THEREOF

Номер: US20130259950A1
Автор: Kim Chun Gi
Принадлежит:

The present invention relates to a dietary supplement capable of treating and preventing symptoms of immune diseases (reduced immunity, allergic disease, and respiratory disease), viral diseases (cold, varicella, and herpes zoster), musculoskeletal diseases (arthritis, traffic accident sequela, sciatica, frozen shoulder, and herniated disk), neurological diseases (insomnia, menopausal disorder, hypothermia, cold hands and feet, dysautonomia, and postpartum pain), and the like. More specifically, the dietary supplement is prepared by the following steps: preparing pettitoes or a pig's head in cold water for about 24 hours to remove blood and to wash the same; preparing by collecting, selecting, and washing the branches and fruits of the ; heating a mixture comprising the prepared pettitoes or pig's head and the branches and fruits of and water in a water bath at 150° C. to 250° C. for about 10 hours; filtering the extract heated in a water bath with a filter and mixing the extract and maple syrup; and boiling the filtered extract at 100° C. for 5 minutes and packaging the same into a pouch. 1Zanthoxylum piperitum. A method for preparing a dietary supplement using pettitoes or a pig's head and , the method comprising:preparing pettitoes or a pig's head by soaking them in cold water for about 24 hours to remove blood and washing the same;{'i': Zanthoxylum piperitum', 'Zanthoxylum piperitum;, 'preparing by collecting, sorting, and washing branches and fruits of the'}{'i': 'Zanthoxylum piperitum', "heating a mixture of the prepared pettitoes or pig's head, the branches and fruits of and water in a water bath at about 150° C. to about 250° C. for about 10 hours;"}filtering the extract heated in the water bath with a filter and mixing the extract with maple syrup; andboiling the filtered and mixed extract at about 100° C. for about 5 minutes and packaging the same into a pouch.2Zanthoxylum piperitum. A method for preparing a dietary supplement using pettitoes or a pig's ...

Подробнее
Номер записи: 44
03-10-2013 дата публикации

TIE2 Activator, Vascular Endothelial Growth Factor (VEGF) Inhibitor, Angiogenesis Inhibitor, Vascular Maturing Agent, Vascular Normalizing Agent and Vascular Stabilizing Agent, and Pharmaceutical Composition

Номер: US20130259952A1
Автор: KISO Akinori, OHTO Nobuaki
Принадлежит:

A Tie2 activator containing, as an active ingredient, a hawthorn extract, a starfruit extract, a shellflower extract, a lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a Quillaja extract, a Kouki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a Chinese wolfberry extract, a chamomile extract, or a Butcher's Broom extract, or any combination thereof. 1. A Tie2 activator comprising , as an active ingredient , a hawthorn extract , a starfruit extract , a shellflower extract , a lotus extract , a rooibos extract , an Indian date extract , a Chinese quince extract , a Psidium guava extract , a long pepper extract , a Quillaja extract , a Kouki extract , a ginkgo extract , an oyster extract , a turmeric extract , a chrysanthemum extract , a jujube extract , a Chinese wolfberry extract , a chamomile extract , or a Butcher's Broom extract , or any combination thereof.2. An angiogenesis inhibitor comprising , as an active ingredient , a hawthorn extract , a starfruit extract , a shellflower extract , a lotus extract , a rooibos extract , an Indian date extract , a Chinese quince extract , a Psidium guava extract , a long pepper extract , a Quillaja extract , a Kouki extract , a ginkgo extract , an oyster extract , a turmeric extract , a chrysanthemum extract , a jujube extract , a Chinese wolfberry extract , a chamomile extract , or a Butcher's Broom extract , or any combination thereof.3. A vascular maturing agent comprising , as an active ingredient , a hawthorn extract , a starfruit extract , a shellflower extract , a lotus extract , a rooibos extract , an Indian date extract , a Chinese quince extract , a Psidium guava extract , a long pepper extract , a Quillaja extract , a Kouki extract , a ginkgo extract , an oyster extract , a turmeric extract , a chrysanthemum extract , a jujube extract , a Chinese wolfberry extract , a ...

Подробнее
Номер записи: 45
10-10-2013 дата публикации

TERMINALIA CHEBULA COMPOSITIONS AND METHOD OF EXTRACTING SAME

Номер: US20130266676A1
Автор: Ghosal Shibnath, Kalidindi Sanyasi R., Veeraragavan Muruganandam
Принадлежит: NATREON, INC.

An enriched hydrolyzable tannoid blend derived from is provided. An optimized aqueous extraction method for is provided to maximize the levels of bioactive hydrolyzable tannoids including chebulagic acid, chebulinic acid and other low molecular weight hydrolyzable tannoids. The method produces a extract containing a hydrolyzable tannoid blend as an amorphous dry powder. In an embodiment, the extract contains 8-25% by weight chebulagic acid, 15-30% chebulinic acid, and 5-45% low molecular weight hydrolyzable tannoids. Potential uses of said enriched hydrolyzable tannoid compositions for antioxidant activity in a human subject are described herein. 1Terminalia chebula. A extract composition comprising a hydrolyzable tannoid blend including about 8-25% by weight chebulagic acid based on the total weight of the extract , and about 15-30% by weight chebulinic acid based on the total weight of the extract.2Terminalia chebula. The extract composition of claim 1 , further comprising about 5-45% by weight other low molecular weight hydrolyzable tannoids based on the total weight of the extract.3. A pharmaceutical claim 1 , nutraceutical claim 1 , or skin care composition comprising the extract of and a pharmaceutically claim 1 , nutraceutically claim 1 , or cosmeceutically acceptable carrier.4Terminalia chebula. The extract composition of claim 1 , wherein chebulagic acid is present in an amount of about 15-20% by weight based on the total weight of the extract claim 1 , and chebulinic acid is present in an amount of about 20-28% by weight based on the total weight of the extract.5Terminalia chebula. A method of making a extract composition comprising a hydrolyzable tannoid blend claim 1 , including the steps of:{'i': 'Terminalia chebula', '(a) providing fruit pericarp portions of a plant;'}{'i': 'Terminalia chebula', '(b) grinding the fruit pericarp plant portions to provide a powder;'}{'i': Terminalia chebula', 'Terminalia chebula, '(c) extracting the fruit pericarp powder ...

Подробнее
Номер записи: 46
24-10-2013 дата публикации

High molecular weight polymeric composition and a new usage of the high-molecular weight polymeric composition

Номер: US20130280292A1
Автор: HSIN SHAO CHI
Принадлежит:

Approach is provided for a high molecular weight polymeric composition and a new usage of the high-molecular weight polymeric composition. The new usage of the high-molecular weight polymeric composition directly adsorbs body fluid, or indirectly adsorbs toxin or stimulating substance existed in the intaked solution or liquid and removes the body fluid or the toxin or stimulating substance out of body. Therefore, the high-molecular weight polymeric composition is helpful to reduce the food digestibility or to prevent the toxin or stimulating substance from adsorbing in the gastrointestinal tract, even to bring the toxin or stimulating substance out of the body. Accordingly, the high-molecular weight polymeric composition is able to be applied to control weight by lowering the food digestibility or avoid damage by decreasing the toxin or stimulating substance released into the body. The high molecular weight polymeric composition has well biocompatibility to be widely applied in human. 1. A new usage of a high-molecular weight polymeric composition being adsorbed a toxin or a stimulating substance existed in a solution that is intaked into the body and removing the toxin or the stimulating substance out of the body to prevent the body from being damaged by the toxin or the stimulating substance.2. The new usage of the high-molecular weight polymeric composition as claimed in claim 1 , wherein the high-molecular weight polymeric composition comprises a high molecular weight fiber claim 1 , a natural fiber claim 1 , a synthesized fiber or a high molecular weight adsorber.3. The new usage of the high-molecular weight polymeric composition as claimed in claim 2 , wherein the natural fiber is selected from a group consisting of: Sterculia BP claim 2 , Frangula BPC claim 2 , collagen claim 2 , cellulose claim 2 , chitin claim 2 , chitosan and a mixture of the4. The new usage of the high-molecular weight polymeric composition as claimed in claim 1 , wherein the high- ...

Подробнее
Номер записи: 47
24-10-2013 дата публикации

PHARMACEUTICAL COMPOSITION AND METHOD FOR REDUCING WEIGHT

Номер: US20130280347A1
Автор: Schnappinger Uta
Принадлежит:

A method for weight reduction, involving pharmaceutical compositions, particularly homeopathic medicines for weight reduction, including the following components: Calcium carbonicum Hahnemann, Cascara, Graphites and Kalium Carbonicum and as well as a nutritient. 1. A method for weight reduction , comprising:administering to a patient in need thereof a pharmaceutical composition of which the medically active components comprise the following with the respective dilutions:{'i': 'Adonis vernalis,', 'D2 up to D9 Dil.,'}Calcium carbonicum Hahnemann, D8 up to D24 Dil.,{'i': 'Capsicum,', 'D2 up to D9 Dil.,'}Cascara, D2 up to D9 Dil.,{'i': 'Fucus vesiculosus,', 'D1 up to D9 Dil.,'}Graphites, D8 up to D24 Dil.,Kalium Carbonicum, D4 up to D12, and{'i': 'Phytolacca,', 'D2 up to D9 Dil., and'}continuing administration until a desired amount of weight reduction has been achieved.2. The method for weight reduction according to claim 1 , wherein the administering is self-administered by the patient by using an applicator.3. The method for weight reduction according to claim 2 , wherein the self-administering by the patient is done with a needle-free trans-mucosal applicator for injecting solvings into the mouth of the patient.4. The method for weight reduction according to claim 3 , wherein the needle-free trans-mucosal applicator for injecting solvings into the mouth of the patient is used three times a day with an exact defined doses of 0.0304 fl oz (0.09 ml) spray volume per stroke.5. The method for weight reduction according to claim 1 , wherein the pharmaceutical composition is present as an alcohol-free aqueous liquid solution.6. The method for weight reduction according to claim 1 , wherein the medically active components consist essentially of the following with the respective dilutions:{'i': 'Adonis vernalis', '1 part D6 Dil.,'}1 part Calcium carbonicum Hahnemann D15 Dil.,{'i': 'Capsicum', '1 part D6 Dil.,'}1 part Cascara D5 Dil.,{'i': 'Fucus vesiculosus', '1 part D4 Dil ...

Подробнее
Номер записи: 48
31-10-2013 дата публикации

COMPOSITIONS FOR PREPARING A COFFEE BEVERAGE COMPRISING HYDROLYSED CHLOROGENIC ACID

Номер: US20130287740A1
Автор: Bel-Rhlid Rachid, Cavin Christophe, Kraehenbuehi Karin, Page Nicolas, Raab Thomas Wolfgang
Принадлежит:

The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage. 1. A kit for preparing a beverage , comprising:a first part comprising a dried coffee extract; anda second part comprising a component selected from the group consisting of a microorganism, an enzyme capable of hydrolysing chlorogenic acids to generate phenolic acids, and combinations thereof.2. The kit of claim 1 , wherein the first part comprises pure soluble coffee.3. The kit of claim 1 , wherein the second part comprises a component selected from the group consisting of milk protein claim 1 , vegetable protein claim 1 , and combinations thereof.4. The kit of claim 1 , wherein the second part comprises a component selected from the group consisting of a creamer claim 1 , a sweetener claim 1 , and combinations thereof.5. The kit of claim 1 , wherein the microorganism capable of hydrolysing chlorogenic acids to generate phenolic acids is a lactic acid bacteria. This application is a continuation of U.S. application Ser. No. 12/990,591, filed Nov. 1, 2010, which is a National Stage of International Application No. PCT/EP09/052,932 filed Mar. 12, 2009, which claims priority to European Patent Application No. 08155449.5, filed Apr. 30, 2008, the entire contents of which is incorporated herein by reference thereto.The present invention relates to compositions for preparing a beverage. The compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. Beverages prepared with the compositions of the invention have improved antioxidant and/or anti-inflammatory ...

Подробнее
Номер записи: 49
31-10-2013 дата публикации

Composition for the regeneration of atrophic tissues

Номер: US20130287757A1
Автор: Fulvio Pedrini, Gianfranco Merizzi, Luisa Gennero, Maurizio Pedrini
Принадлежит: MEDESTEA INTERNAZIONALE SPA

An effective composition is for the therapeutic or cosmetic treatment of atrophic cutaneous and subcutaneous tissues, skin appendages, connective tissues or mucous tissues. The composition includes a combination of a salt of adamantane carboxylic acid, preferably salified with an aromatic and/or adamantane base, with a proteolytic enzyme and/or willow extract, salicylic acid, acetylsalicylic acid, salicylate, or acetylsalicylate. Further active ingredients that are suitable for inclusion in the composition are zinc oxide, vitamins, phytoextracts, sugars, amino acids, minerals, further salts, phytoextracts, ventilated green clay and any combination thereof. The composition has a particular synergy between the constituent elements, and is particularly effective in the treatment of atrophic ulcers or bedsores.

Подробнее
Номер записи: 50
31-10-2013 дата публикации

COMPOSITION FOR PREVENTING OR TREATING LIVER TOXICITY COMPRISING GALGEUNTANG OR LACTIC ACID BACTERIA FERMENTED GALGEUNTANG

Номер: US20130287761A1
Автор: LEE Jae Hoon, LEE Ji Hye, MA Jin Yeul, UM Young Ran
Принадлежит:

The present invention relates to lactic acid fermented Galgeuntang, and a composition comprising the said lactic acid bacteria fermented Galgeuntang or Galgeuntang as an active ingredient, more particularly, to lactic acid fermented Galgeuntang prepared by the steps of inoculating lactic acid bacteria to Galgeuntang, culturing thereof, and fermenting thereof, and a composition for preventing or treating liver toxicity comprising the said fermented Galgeuntang or Galgeuntang. The composition of the present invention has treatment effect on liver toxicity, so that it can be effectively used as a liver function recovering agent or health food for liver function recovery. 113-. (canceled)14. A method for prevention or treatment of liver toxicity comprising the step of administrating a composition comprising either or both of Galgeuntang and lactic acid bacteria fermented Galgeuntang as an active ingredient.15Puerariae radixCinnamomi ramulus. The method according to claim 14 , wherein the Galgeuntang is prepared by hot water extraction of the mixture of medicinal herbs including Galgeun () claim 14 , mahuang claim 14 , ginger claim 14 , jujube claim 14 , licorice claim 14 , peony and gyeji ().16Cinnamomi ramulusPuerariae radix. The method according to claim 14 , wherein the Galgeuntang is prepared by mixing 2-10 parts by weight of mahuang claim 14 , 2-10 parts by weight of ginger claim 14 , 2-10 parts by weight of jujube claim 14 , 1-7 parts by weight of licorice claim 14 , 1-7 parts by weight of peony claim 14 , and 1-7 parts by weight of gyeji () with 12 parts by weight of Galgeun ().17. The method according to claim 14 , wherein the lactic acid bacteria fermented Galgeuntang is prepared by fermenting the Galgeuntang inoculated with lactic acid bacteria.18Bifidobacterium, Lactobacillus, Streptococcus, Leuconostoc, PediococcusLactococcus. The method according to claim 14 , wherein the lactic acid bacteria are selected from the group consisting of claim 14 , and sp. ...

Подробнее
Номер записи: 51
31-10-2013 дата публикации

REFRESHING BEVERAGE

Номер: US20130287871A1
Автор: Coy Johannes
Принадлежит:

The invention relates to a novel sweet-tasting refreshing beverage, which is free of phosphoric acid and instead contains at least 0.3% by weight/volume of gluconic acid, which is low in minerals, specifically contains less than 250 mg/liter of minerals, which is low in sugar, specifically contains at most 2.5% by weight/volume of sugar, wherein these sugars comprise at least 10% weight/weight galactose and in addition a proportion of isomaltulose and/or tagatose, and which has a glycemic index of at most 35 (GI<35). 1. A sweet-tasting refreshing beverage that is low in minerals and is low in sugar comprising:a content of gluconic acid that is at least 0.3 wt/vol %,any content of minerals that is less than 250 mg/liter,a content of sugars that comprises a fraction of galactose that is at least 10 weight-weight % based on the content of sugars, said content of sugars additionally comprising a content of isomaltulose and/or tagatose and/or trehalose and/or ribose, wherein the content of sugars in the beverage is at most 2.5 wt/vol %,and wherein the beverage has a glycemic index of at most 35 (GI<35) and is free from phosphoric acid.2. The beverage as claimed in claim 1 , wherein the content of minerals is less than 150 mg per liter.3. The beverage as claimed in claim 1 , wherein the beverage has a content of fruit juices or fruit juice extracts.4Stevia.. The beverage as claimed in claim 1 , wherein the beverage additionally has a content of5. The beverage as claimed in claim 1 , wherein the beverage comprises a content of caramel coloring and natural flavorings and has a cola-like taste.6. The beverage as claimed in claim 5 , wherein the flavorings are Mentha arvensis and/or coca leaf and/or galangal and/or ginger and/or cardamom and/or kola nut and/or cocoa and/or lime and/or mace and/or clove and/or orange and/or pine and/or mustard seed and/or licorice and/or vanilla and/or lemon and/or cinnamon or extracts thereof.7. The beverage as claimed in claim 1 , wherein ...

Подробнее
Номер записи: 52
07-11-2013 дата публикации

Pharmaceutical composition for strengthening spleen and stomach and preparation method therefor

Номер: US20130295079A1
Автор: Gao Yanhui, Guo Chunsheng, LI Xue, Sun Dejun, Sun Miaonan, Yin Jinlong, Zhao Yizhuo
Принадлежит: Jilin Zixin Pharmaceutical Research Institution LLC

A pharmaceutical composition for strengthening spleen and stomach and a preparation method therefor. The method includes the step of mixing four substances listed below to obtain a mixture, wherein the mixture is the pharmaceutical composition for strengthening spleen and stomach, and the four substances are (A) ginseng ethanol extract, (B) volatile oil of largehead atractylodes rhizome and tangerine peels, (C) aqueous extract of Indian bread, yamaimo, lotus seeds, tangerine peels, liquorice root, hawthorn fruit, germinated barley, largehead atractylodes rhizome and rhizoma alismatis; (D) fermentation broth of fruits and vegetables. 19.-. (canceled)10. A method for preparing a pharmaceutical composition for strengthening spleen and stomach , comprising: mixing following four substances to obtain a mixture , i.e. , the pharmaceutical composition for strengthening spleen and stomach; wherein the four substances are (A) ginseng ethanol extract , (B) volatile oil of largehead atractylodes rhizome and tangerine peel , (C) aqueous extract of Indian bread , yamaimo , lotus seed , tangerine peel , liquorice root , hawthorn fruit , germinated barley , largehead atractylodes rhizome and rhizoma alismatis , and (D) fermentation broth of fruits and vegetables ,the substance (A) is prepared by a method comprising a step of extracting an extract from ginseng with ethanol water by a reflux extraction to obtain the ginseng ethanol extract,the substance (B) is prepared by a method comprising steps of soaking largehead atractylodes rhizome and tangerine peel in water, distilling the largehead atractylodes rhizome and the tangerine peel to obtain distillate and dregs, and collecting the distillate to obtain the volatile oil of largehead atractylodes rhizome and tangerine peel,the substance (C) is prepared by a method comprising steps of mixing Indian bread, yamaimo, lotus seed, liquorice root, hawthorn fruit, germinated barley, rhizoma alismatis, the dregs obtained in preparation of ...

Подробнее
Номер записи: 53
07-11-2013 дата публикации

Medical compositions, methods of making and using those compositions, and kits including those compositions

Номер: US20130295172A1
Автор: Freeman Keith Gerald
Принадлежит:

Disclosed here are compositions comprising powdered hemp seed, an emulsifier/dispersant such as lecithin (particularly soya lecithin), cannabis, and optionally other additives and excipients. Also described are methods of making the compositions. The compositions may be used, for instance, in the treatment of pain and for their anti-emetic (anti-nausea and anti-vomiting) properties, as well as for the treatment of anorexia and appetite enhancement. Kits containing the compositions, arranged for proper sequential dosing, and optionally including instructions for use are also disclosed. 1. A composition comprising:a.) powdered hemp seed,b.) lecithin, andc.) cannabis.2. The composition of where the lecithin comprises soy lecithin.3. The composition of where the composition is in the form of a hard-shelled gelatin or plant vegetarian capsule or tablet.4. The composition of further comprising one or more excipients.5. A kit comprising the composition of in multiple dosage forms claim 1 , a package claim 1 , and directions for use.6. A method for producing the composition of comprising the steps of:a.) mixing powdered hemp seed, lecithin, and cannabis to form a mixture,b.) grinding the mixture formed in step a.), andc.) heating the mixture to decarboxylate any THC-carboxy present in the cannabis.7. A method for producing the composition of comprising the steps of:a.) mixing powdered hemp seed, lecithin, and cannabis to form a mixture,b.) grinding the mixture formed in step a.),c.) heating the mixture to decarboxylate any THC-carboxy present in the cannabis,d.) introducing the mixture containing the decarboxylated THC into hard-shelled gelatin or plant vegetarian capsules or forming tablets. This patent application claims priority to U.S. Provisional Patent Application Ser. No. 61/685,956, entitled “Medical Compositions, Methods of Making and Using Those Compositions, And Kits Including Those Compositions” filed on Mar. 28, 2012, which application is hereby incorporated by ...

Подробнее
Номер записи: 54
07-11-2013 дата публикации

FORMULATIONS COMPRISING SAPONINS AND USES THEREOF

Номер: US20130295204A1
Автор: Silberstein Tova
Принадлежит: Y&B Mother's Choice Ltd.

Provided is a formulation including various natural extracts for a variety of human applications. 149.-. (canceled)50Lonicera, Populus, SalixWasabia. A composition comprising at least one saponin material and an extract from at least one plant species of a genus selected from the group consisting of , and or a mixture thereof.51. The composition according to claim 50 , wherein the saponin material is selected from the group consisting of at least one naturally obtained saponin compound claim 50 , at least one saponin-containing extract and a mixture thereof.52. The composition according to claim 50 , wherein the saponin material is obtained by extraction from a plant source claim 50 , said extraction process being carried out by water claim 50 , alcohol or a water/alcohol solution.53. The composition according to claim 52 , wherein the water/alcohol solution has a water:alcohol ratio selected from the group consisting of a ratio of between 80:20 and 20:80 claim 52 , a ratio of between 60:40 and 40:60 claim 52 , a ratio of between 70:30 and 30:70 and 50:50.54Camellia sinensis, Camellia oleifera, Saponaria officinalisSapindus mukorossi. The composition according to claim 50 , wherein the saponin material is an extract selected from the group consisting of claim 50 , or or a mixture thereof.55. The composition according to claim 50 , wherein the saponin material is extracted from a plant source following a method comprising:1. treating the plant source in a water:alcohol solution having a water:alcohol ratio of between 40:60 and 60:40 for a period of time and under conditions permitting extraction of the saponin material from said plant source into said solution;2. optionally, evaporating the saponin-containing solution to obtain a saponin-containing solid material; and3. optionally, purifying said saponin-containing solid material.56. The composition according to claim 55 , wherein the water:alcohol ratio is 50:50.57Camellia oleiferaSapindus mukorossi.. The ...

Подробнее
Номер записи: 55
14-11-2013 дата публикации

USE OF A PLANT EXTRACT, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

Номер: US20130302419A1
Автор: Da Silva Avaniel Marinho, Dos Santos Severino Barbosa, Lima E Moura Tulio Flávio Accioly
Принадлежит: HEBRON FARMACEUTICA PESQUISA, DESENVOLVIMENTO E INOVACAO TECNOLOGICA LTDA

The present invention relates to the use of a plant extract obtained from at least one plant of the Anacardiaceae family, for the preparation of a pharmaceutical composition used as a new herbal medicine for the prophylaxis and/or treatment of disorders associated with the digestive tract, and the relief of symptoms associated with these disorders. Additionally, through the scope of the present invention, the substances isolated from said extract also consist of the active ingredients of pharmaceutical compositions. A third objective of the invention is the use of said pharmaceutical compositions in the preparation of the class of herbal medicines for the prophylaxis and/or treatment of disorders associated with the digestive tract, in different stages, with posology and daily dosing. 1. The use of a plant extract obtained from at least one plant of the Anacardiaceae family wherein the crude extract is used in the preparation of an herbal medicine for the prophylaxis and/or treatment of disorders associated with the digestive tract.2H. pylori. The use of a plant extract claim 1 , according to claim 1 , wherein said extract has activity on gastric mucosal lesions claim 1 , such as peptic ulcers claim 1 , gastritis claim 1 , gastropathy claim 1 , peptic ulcer disease claim 1 , inflammation caused by and duodenitis in different stages.3SchinusAstronium.. The use according to claim 1 , wherein the plant species is selected among the species of the genus or4Schinus andinus, Schinus angustifolius, Schinus antiarthriticus, Schinus areira, Schinus bituminosus, Schinus bonplandianus, Schinus brasiliensis, Schinus bumelioides, Schinus cabrerae, Schinus chebataroffi, Schinus chichita, Schinus crenatus, Schinus dentatus, Schinus dependens, Schinus discolor, Schinus diversifolius, Schinus engleri, Schinus fagara, Schinus fasciculatus, Schinus ferox, Schinus gracilipes, Schinus huigan, Schinus huygan, Schinus indicus, Schinus johnstonii, Schinus kauselii, Schinus latifolius, ...

Подробнее
Номер записи: 56
21-11-2013 дата публикации

PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE SUBSTANCE

Номер: US20130309218A1
Автор: Fukumi Hiroshi, Jo Ayako, Nakata Daisuke, Terao Keiji, Uekaji Yukiko
Принадлежит: Wacker Chemie AG

The purpose of the present invention is to provide a process for producing an aqueous solution containing a fat-soluble substance. A combination of a super dissolution aid, cyclodextrin and a fat-soluble substance or a combination of the super dissolution aid and a cyclodextrin complex of the fat-soluble substance is used for dissolving the fat-soluble substance, whereby it becomes possible to provide an aqueous solution containing the fat-soluble substance at a high concentration and an aqueous solution having improved transdermal absorbability of the fat-soluble substance contained therein. 1. A method for producing an aqueous solution containing at least one fat-soluble substance selected from the group consisting of: polyphenols , flavonoids , tocopherols , retinols , menaquinones , carotenoids , propolis or cinnamic acid derivatives , diterpenes , terpenes , coenzyme Q10 and α-lipoic acid , said method comprising adding to water a solubilizer and at least one of (a) cyclodextrin and the at least on fat-soluble substance , wherein the solubilizer is a member selected from the group consisting of:1) an alkali salt or bile acid selected from the group consisting of taurocholate, glycocholate, cholic acid, lithocholic acid and deoxycholic acid,2) glycosides of polyphenols or hesperidin,3) an emulsifier selected from the group consisting of glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, and, sucrose fatty acid ester,4) a lecithin agent selected from the group consisting of enzymatically decomposed lecithin, lecithin derived from soybean and, lecithin derived from egg yolk,5) a saponin selected from the group consisting of glycyrrhizic acid or an alkali salt thereof, soybean saponin and quillaja saponin,6) a casein or alkali salt thereof,7) a polysorbate (fatty acid polyoxyethylene sorbitan),8) a cellulose or alkali salt thereof selected from the group consisting of methylcellulose, carboxymethyl cellulose and hydroxyethyl ...

Подробнее
Номер записи: 57
21-11-2013 дата публикации

COMPOSITION FOR PREVENTING OR TREATING DEMENTIA CONTAINING PRUNUS MUME EXTRACT

Номер: US20130309334A1
Автор: CHOI Goya, HAN Chang Hyun, Han Jung-Soo, Jeon Won Kyung
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a composition for preventing or treating dementia containing an extract of (Fructus Mume), and the extract of the present invention has outstanding effects in improving spatial recognition ability and in normalizing hippocampal damage (normalizing ERK phosphorylation, increasing ChAT and normalizing NF-kappa B) induced by chronic vascular brain damage in a vascular dementia animal model, and hence can be used to advantage as a medicinal product for preventing or treating dementia diseases and as a functional health food for preventing or alleviating dementia diseases that accompany vascular brain damage such as vascular dementia. 1. A method for the treatment of dementia containing the step of administering a pharmaceutically effective dose of Fructus Mume extract to a subject having dementia.2. The method for the treatment of dementia according to claim 1 , wherein the extract is extracted by using water claim 1 , alcohol claim 1 , or the mixture thereof as a solvent.3. The method for the treatment of dementia according to claim 2 , wherein the alcohol is C-Clower alcohol.4. The method for the treatment of dementia according to claim 3 , wherein the lower alcohol is ethanol or methanol.5. The method for the treatment of dementia according to claim 1 , wherein the extract is extracted by ultrasonification/heat combined extraction.6. The method for the treatment of dementia according to claim 1 , wherein the dementia is vascular dementia or Alzheimer's disease.713-. (canceled) 1. Field of the InventionThe present invention relates to a composition for preventing or treating dementia containing Fructus Mume extract.2. Description of the Related ArtDementia is diagnosed when memory disorder is so severe as to bring difficulty in daily life including work, social life, and personal relationship with accompanying at least one of the following 4 symptoms; speech disorder, disorientation, decline of calculation ability, and character & ...

Подробнее
Номер записи: 58
05-12-2013 дата публикации

Method Of Using Rhein For Treating Fibrotic Conditions And Tumors

Номер: US20130323329A1
Автор: BIAN Zhaoxiang, CHAN Albert Sun-Chi, Chen Shilin, LU Aiping, QIN Hongyan, TSANG Siu Wai, XIAO Haitao, XU Hongxi, YANG Dajian
Принадлежит: HONG KONG BAPTIST UNIVERSITY

The present invention relates to a method of using an anthraquinone derivative namely 9,10-Dihyro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid, or known as Rhein, for treating chronic pancreatitis induced fibrosis of the pancreas. More particularly, the present invention relates to a method of using Rhein, its derivatives and/or chemical variants as an anti-fibrotic agent. The present invention particularly relates to the suppression of pancreatic stellate cell activation for the management of chronic inflammatory, fibrotic and tumorigenic pathologies in the pancreas. 2. The method according to wherein the subject is a human.3. The method according to wherein the composition is administered orally.4. The method according to wherein the fibrotic conditions comprising pancreatic fibrosis and fibrotic related diseases comprising chronic pancreatitis.5. The method according to wherein at least 50 milligram/kilogram body weight/day of said composition is administered to said subject in single dose for a continuous duration of at least 3 weeks.7. The method according to wherein the subject is a human.8. The method according to wherein the composition is administered orally.9. The method according to wherein the pancreatic tumors or pancreatic tumors related diseases comprising pancreatic ductal adenocarcinoma.10. The method according to wherein said extract claim 6 , compound claim 6 , the derivatives or chemical variants thereof inhibits the activation of pancreatic stellate cells.11. The method according to wherein at least 50 milligram/kilogram body weight/day of said composition is administered to said subject in single dose for a continuous duration of at least 3 weeks. The present application claims priority of U.S. provisional application No. 61/655,472 filed Jun. 4, 2012, and which the disclosure is hereby incorporated by reference in its entirety.The present invention relates to a method of using Rhein for treating chronic pancreatitis induced fibrosis of ...

Подробнее
Номер записи: 59
05-12-2013 дата публикации

Use Of Compositions For Preventing Chemotherapy And Radiotherapy Induced Alopecia (CRIA), Reducing CRIA Impact And Improving The Appearance Of Hair Re-Growth After CRIA

Номер: US20130323334A1
Автор: Harti Saad
Принадлежит: LEGACY HEALTHCARE LTD.

Compositions administered by topical route contain as active ingredients an extract of species, an extract of species, an extract of species and an extract of species, for preventing CRIA, reducing CRIA impact and improving the appearance of hair re-growth after CRIA. A method for preventing, reducing impact and improving the appearance of hair re-growth on a human head before, during and after CRIA, said method comprising the administration by topical route of a composition containing as active ingredient an extract of species, an extract of species, an extract of species and an extract of species. 1AlliumCitrusPaulliniaTheobroma. A method for preventing CRIA , reducing CRIA impact and improving the appearance of hair re-growth after CRIA , the method comprising administering by topical route to a subject in need thereof of a composition containing as active ingredients an extract of species , an extract of species , an extract of species and an extract of species.2AlliumCitrusPaulliniaTheobroma. The method for preventing claim 1 , reducing impact and improving the appearance of hair re-growth according to claim 1 , for patients before claim 1 , during and after CRIA claim 1 , wherein the composition further comprises an aqueous-alcoholic extract of species claim 1 , an aqueous-alcoholic extract of species claim 1 , an aqueous alcoholic extract (atomised or not) of species and an aqueous-alcoholic extract (atomised or not) of species.3AlliumCitrusPaulliniaTheobroma. The method according to claim 1 , wherein the composition further comprises from 65% to 93% of an aqueous-alcoholic extract of species claim 1 , from 5% to 33% of an aqueous-alcoholic extract of species claim 1 , from 0.25% to 2.5% of an aqueous alcoholic extract of species and from 0.25% to 2.5% of an aqueous-alcoholic extract of species.4. The method according to claim 1 , further comprising administering the composition daily during a period of several months.5. The method according to claim 1 , ...

Подробнее
Номер записи: 60
05-12-2013 дата публикации

PLANT EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFECTIONS

Номер: US20130323335A1
Автор: Jung DaiHyun, Kim SuJung, Lee JungHun, Moh SangHyun, Rozenblat Sharon
Принадлежит:

A composition comprising a plant extract and at least one additional plant extract selected from the group consisting of an plant extract, a plant extract, a plant extract, a plant extract and a plant extract is disclosed. Compositions comprising plant extract or Ailanthone are also disclosed. 180-. (canceled)81Sanguisorbae officinalisAilanthus altissima. A method of treating and/or preventing infection in a subject in need thereof , the method comprising administering to the subject a therapeutically effective amount of a composition comprising a plant extract and an plant extract , thereby treating and/or preventing infection in the subject.82. The method of claim 81 , wherein said infection is secondary to chronic inflammation.83. The method of claim 81 , wherein said infection is secondary to atopic dermatitis.84Sanguisorbae officinalisAilanthus altissima. A method of treating and/or preventing atopic dermatitis in a subject in need thereof claim 81 , the method comprising administering to the subject a therapeutically effective amount of a composition comprising a plant extract and an plant extract claim 81 , thereby treating and/or preventing infection in the subject.85. The method of claim 81 , wherein said infection is associated with a disease selected from the group consisting of an atopic disease claim 81 , a contact dermatitis claim 81 , a nummular dermatitis claim 81 , a radiation dermatitis claim 81 , a burn claim 81 , a non-atopic eczema claim 81 , a pressure sore claim 81 , an eye inflammatory disease claim 81 , a respiratory inflammatory diseases claim 81 , an asthma claim 81 , a gastrointestinal disease and an oral infectious disease.86. The method of claim 81 , wherein said therapeutically effective amount is for downregulating secretion of a Th2 type cytokine selected from the group consisting of IL-4 claim 81 , IL-5 claim 81 , IL-6 claim 81 , IL-10 and IL-13 in a cell of said subject.87. The method of claim 81 , wherein said therapeutically ...

Подробнее
Номер записи: 61
05-12-2013 дата публикации

NOVEL HERBAL COMPOSITION FOR THE TREATMENT OF WOUND HEALING, A REGENERATIVE MEDICINE

Номер: US20130323337A1
Автор: Patankar Suresh Balkrishna
Принадлежит:

The present invention discloses a novel, synergistic, effective herbal composition as a regenerative medicine comprising combination therapeutically effective amounts of extracts obtained from and , along with optionally comprising Pig fat in (Til) oil as a base, useful for the treatment of wound healing. The present invention also discloses a process for preparation of said herbal composition. 1. A novel , synergistic , effective herbal composition as a regenerative medicine for the treatment of wound healing comprising ,{'i': 'Curcuma longa', 'extracts of in an amount of about 5 to 15%;'}{'i': 'Glycyrrhiza glabara', 'extracts of in an amount of about 2 to 30%;'}{'i': 'Hamiltonia suaveolens', 'extracts of in an amount of about 2 to 50%;'}{'i': 'Typha angustifolia', 'extracts of in an amount of about 1 to 50%; and'}{'i': 'Azadirachta indica', 'extracts of in an amount of about 0.5 to 30% of the total composition.'}2Sesamum indicum. The herbal composition as claimed in claim 1 , wherein said composition further comprises oil as a base.3Sesamum indicum. The herbal composition as claimed in claim 2 , wherein oil is present in an amount of about 20 to 60% of the total composition.4. The herbal composition as claimed in claim 3 , wherein said composition comprises claim 3 ,{'i': 'Curcuma longa', 'extracts of in an amount of about 7 to 13%;'}{'i': 'Glycyrrhiza glabara', 'extracts of in an amount of about 5 to 20%;'}{'i': 'Hamiltonia suaveolens', 'extracts of in an amount of about 5 to 30%;'}{'i': 'Typha angustifolia', 'extracts of in an amount of about 2 to 40%;'}{'i': 'Azadirachta indica', 'extracts of in an amount of about 1 to 25% and'}{'i': 'Sesamum indicum', 'oil as a base in an amount of about 25 to 55% of the total composition.'}5. The herbal composition as claimed in claim 3 , wherein said composition comprises claim 3 ,{'i': 'Curcuma longa', 'extracts of in an amount of about 10 to 12%;'}{'i': 'Glycyrrhiza glabara', 'extracts of in an amount of about 8 to 15 ...

Подробнее
Номер записи: 62
05-12-2013 дата публикации

COMPOSITION COMPRISING BANYAN TREE, LOTUS, AND CLOVER SERUM FRACTIONS (AGING)

Номер: US20130323339A1
Автор: DUEVA-KOGANOV Olga, KOGANOV Michael
Принадлежит: AKZO NOBEL SURFACE CHEMISTRY LLC

The present invention relates to compositions comprising banyan tree, lotus, and clover serum fractions. A method of improving the appearance of aging skin may comprise the step of applying a composition comprising an effective amount of banyan tree serum fraction, lotus serum fraction, and clover serum fraction to a sign of aging on a skin surface, wherein the composition is applied for a period of time sufficient to improve the appearance of the aging skin. The method may include the step of identifying a sign of aging on a facial skin surface. 1. A serum fraction blend suitable for use in formulating topically applied skin compositions , said blend comprising:a. Banyan tree serum fraction;{'i': 'Lotus', 'b. serum fraction; and'}c. Clover serum fraction.2. The serum fraction blend of claim 1 , wherein each of said banyan tree claim 1 , lotus claim 1 , and clover serum fractions are produced by the process comprising:a. separating plant cell juice from clean, fresh, un-wilted plant matter to obtain fresh plant cell juice, wherein no exogenous liquid is added prior or during said separating;b. filtering said fresh plant cell juice to obtain fiber-free cell juice; andc. fractionating said fiber-free cell juice to obtain said serum fractions.3. The serum fraction blend of which comprises:a. from 0.001% to 15% Banyan tree serum fraction;{'i': 'Lotus', 'b. from 0.001% to 15% serum fraction; and'}c. from 0.001% to 15% Clover serum fraction.4. The serum fraction blend of which comprises:a. from 0.002% to 10% Banyan tree serum fraction;{'i': 'Lotus', 'b. from 0.002% to 10% serum fraction; and'}c. from 0.002% to 10% Clover serum fraction.5. The serum fraction blend of which comprises:a. from 0.025% to 10% Banyan tree serum fraction;{'i': 'Lotus', 'b. from 0.025% to 10% serum fraction; and'}c. from 0.025% to 10% Clover serum fraction.6. The serum fraction blend of which comprises:a. from 0.05% to 5% Banyan tree serum fraction;{'i': 'Lotus', 'b. from 0.05% to 5% serum ...

Подробнее
Номер записи: 63
12-12-2013 дата публикации

TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS

Номер: US20130330426A1
Автор: Florence Tiffany, Gan David, Hines Michelle
Принадлежит: MARY KAY INC.

Disclosed are compositions that include extracts from a and 1. A topical skin composition comprising:{'i': 'Lonicera maackii', '(a) an effective amount of an extract from the plant of , wherein said extract is capable of reducing TNF-α or elastase activity in skin; and'}{'i': 'Polygonum', '(b) an effective amount of an extract from the plant of hydropiper, wherein said extract is capable of reducing oxidation in skin or reducing TNF-α or elastase activity in skin.'}2. The topical skin composition of claim 1 , wherein the composition is a lotion claim 1 , cream claim 1 , or gel.3. The topical skin composition of claim 1 , wherein the composition is an emulsion.4Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the and extracts are aqueous extracts.5Lonicera maackiiPolygonum hydropiper. The topical skin composition of claim 1 , wherein the composition comprises from 0.01% to 20% by weight of extract and 0.01% to 20% by weight of extract.6. The topical skin composition of claim 1 , wherein the composition further comprises water.7. The topical skin composition of claim 7 , wherein the composition further comprises an emulsifier. This application is a divisional of U.S. application Ser. No. 13/323,402, filed Dec. 12, 2011, which is a continuation of U.S. Pat. No. 8,273,387, filed Aug. 26, 2010, which claims the benefit of U.S. Provisional Application No. 61/237,087, filed Aug. 26, 2009. The contents of the referenced applications are incorporated into the present application by reference.A. Field of the InventionThe present invention relates generally to compositions that include one or any combination of plant extracts selected from the group consisting of: ; and ; and any combination of extracts thereof. In particular aspects, the compositions include an extract selected from the group consisting of: extract; extract; extract; and extract; and any combination thereof. The compositions can be formulated as topical skin compositions ...

Подробнее
Номер записи: 64
19-12-2013 дата публикации

PLANT EXTRACTS FOR TREATING BURNS AND CHRONIC WOUNDS

Номер: US20130337090A1
Автор: Doron Shirli
Принадлежит: SKIN MATRIX LTD.

The present invention provides compositions and methods for treating burns and chronic wounds, particularly compositions comprising an oil extract or oily suspension of a combination of plant material derived from several plant species for treating burns and chronic sores. 1Harpagophytum procumbensAngelica archangelica. A composition comprising as an active ingredient an oil extract or oily suspension of a combination of ground roots of (Devil's claw) and (Angelica).2Hydrastis canadensis. The composition of claim 1 , wherein the active ingredient further comprises an oil extract or oily suspension of ground roots of (Golden Seal).3Astragalus membranaceousSymphytum officinaleUrtica dioica. The composition of claim 1 , further comprising an oil extract or oily suspension of at least one of ground root of (Astragalus); ground leaves of (Comfrey) ground leaves of (Stinging Nettle) or any combination thereof.4Agrimonia Eupatoria. The Composition of claim 3 , further comprising an oil extract or oily suspension of ground leaves of (Agrimony) and ground blue-green algae.5Harpagophytum procumbensAngelica ArchangelicaAstragalus membranaceousSymphytum officinaleUrtica dioicaAgrimonia Eupatoria. The composition of comprising as an active ingredient an oil extract or oily suspension of a combination of ground plant material comprising roots of (Devil's claw) claim 4 , (Angelica) and (Astragalus); leaves of (Comfrey) claim 4 , (Stinging Nettle) and (Agrimony); and blue-green algae.6Hydrastis Canadensis. The composition of claim 5 , wherein the active ingredient further comprises an oil extract or oily suspension of ground roots of (Golden Seal).7Harpagophytum procumbensAngelica ArchangelicaAstragalus membranaceousSymphytum officinaleUrtica dioicaAgrimonia Eupatoria. The composition of claim 5 , consisting of an oil extract or oily suspension of a combination of ground plant material consisting of roots of (Devil's claw) claim 5 , (Angelica) and (Astragalus); leaves of (Comfrey) ...

Подробнее
Номер записи: 65
19-12-2013 дата публикации

COMPOSITION COMPRISING NATURAL EXTRACTS

Номер: US20130337093A1
Автор: FARAGGI Eli
Принадлежит:

The invention relates to a method for providing an awaking effect and specifically affecting post lunch dip in a subject comprising providing a subject with a composition comprising an isolate of guarana plant, and at least one of (i) isolate of plant or functional analogue thereof and (ii) fruit sugars, wherein the composition does not affect the subject's heart activity. The invention further provides a method for affecting post lunch dip in a subject, comprising administering to the subject a daily dose of a composition comprising (i) an isolate of guarana plant, (ii) an isolate of plant or functional analogue thereof and (iii) fruit sugars for a period of at least 7 days. 1ginkgo biloba. A method for providing an awaking effect on a subject , the method comprises providing a subject with a composition comprising an isolate of guarana plant , and at least one of (i) isolate of plant or functional analogue thereof and (ii) fruit sugars , wherein the composition does not affect the subject's heart activity.2. The method of claim 1 , comprising determining the subject's heart activity by one or more parameters selected from the group consisting of heart rate and blood pressure.3. The method of claim 1 , comprising determining heart activity within a time window of up to 24 hours post administration of said composition.4ginkgo biloba. The method of claim 1 , wherein the composition comprising (i) an isolate of guarana plant claim 1 , (ii) an isolate of plant or functional analogue thereof and (iii) fruit sugars.5. The method of claim 1 , for providing an effect selected from the group consisting of ameliorating claim 1 , reducing and inhibiting development of post lunch dip.6. The method of claim 1 , comprising daily administration of the composition during a period of at least 7 days.7. The method of claim 1 , wherein said daily dose is administered once or twice a day.8. The method of claim 1 , comprising administration of said composition during a period of at ...

Подробнее
Номер записи: 66
26-12-2013 дата публикации

CONCENTRATION AND MENTAL PERFORMANCE AMPLIFYING FORMULATION

Номер: US20130344141A1
Автор: BUCKLEY Michael Scott
Принадлежит:

A concentration and mental performance amplifying formulation comprising and geranium oil, together with at least one of vinpocetine, phosphatidylcholine, caffeine and (White Willow Bark). In another aspect, there is disclosed a concentration and mental performance amplifying formulation comprising: geranium oil, and at least one of anhydrous caffeine and nicotine. In yet another aspect, there is disclosed a concentration and mental performance amplifying formulation as last described which further comprises: Vinpocetine, or Vincamine together with Huperzine-A, or (Periwinkle) together with Huperzine-A; PhosphatidylCholine or (Brahmi) or Nicotinamide Adenine Dinucleotide Hydrate; and (White Willow Bark). Also described is a method of amplifying concentration and mental performance in a human subject by administering such formulations to such a subject. 1rhodiola rosea,Salix alba. A method for amplifying concentration and mental performance in a human subject in need of such amplification , which comprises administering to said subject a formulation comprising a concentration and mental performance amplifying formulation comprising geranium oil , vinpocetine , phosphatidylcholine , caffeine and (White Willow Bark).2. A method as claimed in wherein the formulation comprises a concentration and mental performance amplifying formulation comprising: rhodiola rosea claim 1 , geranium oil claim 1 , and at least one of anhydrous caffeine and nicotine.3Vinca minorBacopa monnieriMucuna pruriens;Salix alba. A method as claimed in wherein the formulation comprises the concentration and mental performance amplifying formulation further comprising: Vinpocetine claim 1 , or Vincamine together with Huperzine-A claim 1 , or (Periwinkle) together with Huperzine-A; PhosphatidylCholine or (Brahmi) or Nicotinamide Adenine Dinucleotide Hydrate; and (White Willow Bark).4. A method as claimed in wherein the formulation comprises the concentration and mental performance amplifying ...

Подробнее
Номер записи: 67
26-12-2013 дата публикации

Bioactive Fractions and Compounds from Polygonum genus, their Use in Anti-diarrhea and the Method of Preparation

Номер: US20130344174A1
Автор: BIAN Zhaoxiang, CHAN Albert Sun-Chi, Chen Shilin, LU Aiping, XIAO Haitao, XU Hongxi, YANG Dajian
Принадлежит: HONG KONG BAPTIST UNIVERSITY

The present invention discloses the utility of factions and compounds from Linn in anti-diarrhea. The invention also includes their preparation and application method for anti-diarrhea treatment. 2. The composition of claim 1 , wherein the composition comprises bioactive fractions claim 1 , compounds or extract from a herb from the family of Polygonaceae claim 1 , the composition is orally administered to the subject in need thereof at a dosage of no less than 1.117 gram/kilogram body weight/day.3. The composition of claim 2 , wherein the dosage is 2.355 gram/kilogram body weight/day.4. The composition of claim 2 , wherein the dosage is 4.710 gram/kilogram body weight/day.5. The composition of claim 1 , wherein the compound is formula (1) claim 1 , and the composition is orally administered to the subject in need thereof at a dosage of no less than 15 milligram/kilogram body weight/day.6. The composition of claim 5 , wherein the dosage is 30 milligram/kilogram body weight/day.7. The composition of claim 1 , wherein the compound is formula (2) claim 1 , and the composition is orally administered to the subject in need thereof at a dosage of no less than 30 milligram/kilogram body weight/day.8. The composition of claim 7 , wherein the dosage is 60 milligram/kilogram body weight/day.9Polygonum chinense. The composition of claim 1 , wherein the herb is Linn.10. The composition of claim 1 , wherein the subject is a human.11. The composition of claim 1 , wherein the diarrhea related diseases comprising enteritis claim 1 , dysentery claim 1 , inflammatory bowel disease claim 1 , irritable bowel syndrome claim 1 , irritable pouch syndrome.12. A method for prevention and treatment of diarrhea and related diseases comprising administering the composition of to a subject in need thereof.13. A method of preparing bioactive fractions or compounds from a herb of Polyonaceae family for treatment of diarrhea and related diseases comprisingextracting a viscous ethanol extract from ...

Подробнее
Номер записи: 68
26-12-2013 дата публикации

METHODS AND COMPOSITIONS FOR TREATMENT OF ADD/ADHD, DEPRESSION, MEMORY PROBLEMS AND OTHER CONDITIONS

Номер: US20130344176A1
Автор: Gazley Jef
Принадлежит:

Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions. 1. A method for treating attention deficit hyperactivity disorder , comprising orally administering to a human subject affected with said disorder a composition comprising 1 to 3 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.2. The method of claim 1 , wherein the composition comprises 3 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.3. The method of claim 2 , wherein the composition comprises 10 to 15 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.4. The method of claim 1 , wherein the composition further comprises one or more nutritional supplements.5. The method of claim 2 , wherein the composition further comprises one or more nutritional supplements.6. The method of claim 3 , wherein the composition further comprises one or more nutritional supplements.7. The method of claim 4 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 4 , pycnogenol claim 4 , L-tyrosine claim 4 , Ginko biloba claim 4 , DMAE claim 4 , Gotu kola claim 4 , Guarana claim 4 , L-5HTP claim 4 , magnesium claim 4 , and zinc.8. The method of claim 5 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 5 , pycnogenol claim 5 , L-tyrosine claim 5 , Ginko biloba claim 5 , DMAE claim 5 , Gotu kola claim 5 , Guarana claim 5 , L-5HTP claim 5 , magnesium claim 5 , and zinc.9. The method of claim 6 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 6 , ...

Подробнее
Номер записи: 69
23-01-2014 дата публикации

WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS OF HOPS RESINS

Номер: US20140023599A1
Автор: Kuhrts Eric H.
Принадлежит: BIOACTIVES, INC.

The present invention is drawn to water-soluble compositions for providing hops constituents, particularly alpha acids, iso-alpha acids, and beta acids. A pharmaceutical gel composition can comprise a hops extract and a surfactant. Such compositions can be formulated into products for various therapeutic applications, including oral and topical uses. Such compositions can also be dissolved in water to yield a clear solution containing more dilute hops acids. The invention also provides methods of treatment comprising administering water-soluble hops compositions. The present invention is also drawn to methods for making water-soluble preparations of hops constituents. 1. A pharmaceutical gel composition , comprising:from 0.2 wt % to 70 wt % hops extract including from 0.25 wt % to 49.5 wt % of a combination of alpha acids and iso-alpha acids and from 0.05 wt % to 25 wt % beta acids in said composition; andfrom 30 wt % to 99.8 wt % non-ionic surfactant selected from the group consisting of monoglycerides, diglycerides, triglycerides, mono-fatty acid esters of polyethylene glycol, di-fatty acid esters of polyethylene glycol, sorbitan fatty acid esters, polyglycolyzed glycerides, triblock copolymers, and mixtures thereof,wherein the gel composition is free of visible particles of hops extract and is water-soluble.2. A composition as in claim 1 , wherein the non-ionic surfactant is selected from the group consisting of monoglycerides claim 1 , diglycerides claim 1 , triglycerides claim 1 , and mixtures thereof.3. A composition as in claim 1 , wherein the composition is formulated into a product form selected from the group consisting of toothpastes claim 1 , creams claim 1 , ointments claim 1 , lotions claim 1 , salves claim 1 , nasal mists claim 1 , and oral rinses.4. A composition as in claim 1 , wherein the composition is formulated into a toothpaste.5. A method of treating an oral cavity of a subject claim 4 , comprising applying a therapeutically effective amount ...

Подробнее
Номер записи: 70
23-01-2014 дата публикации

HERBAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES AND IMPROVING MEMORY IMPAIRMENT

Номер: US20140023677A1
Автор: Kim Dong Sik, Kim Seon Hee, Lee Doo Suk
Принадлежит: VIROMED CO., LTD.

The present invention relates to a composition for preventing or treating neurological diseases including an extract of fruit, red sage and as an active ingredient. The composition of the present disclosure has a superior effect of inhibiting the activity of acetylcholinesterase (AChE), which hydrolyzes the neurotransmitter acetylcholine directly involved in impairment of cognitive function. In addition, the composition of the present disclosure is safe for the human body since the biologically safe extract of fruit, red sage and is used as the active ingredient. 112-. (canceled)13Euphoria longanGastrodia elata. A method for preventing or treating neurological diseases , comprising: administering to a subject a composition comprising an extract of a mixture of fruit , red sage and as an active ingredient.14. The method according to claim 13 , wherein the composition is a pharmaceutical composition or food composition.15Euphoria longanGastrodia elata. A method for improving brain or cognitive function claim 13 , comprising: administering to a subject a composition comprising an extract of a mixture of fruit claim 13 , red sage and as an active ingredient.16. The method of claim 13 , wherein the neurological disease is selected from a group consisting of degenerative nerve disease and mental disorder.17. The method of claim 16 , wherein the degenerative nerve disease is a neurological disease selected from a group consisting of dementia claim 16 , Alzheimer's disease claim 16 , Huntington's disease claim 16 , Parkinson's disease and amyotrophic lateral sclerosis.18. The method of claim 16 , wherein the mental disorder is selected from a group consisting of depression claim 16 , schizophrenia and posttraumatic stress disorder.19. The method of claim 15 , wherein the brain or cognitive function is learning ability claim 15 , memory or concentration.20. The method of claim 19 , wherein the method is for improving memory impairment.21ophiopogonCnidium officinale, Angelica ...

Подробнее
Номер записи: 71
30-01-2014 дата публикации

COMPOSITION FOR PREVENTING OR TREATING A RESPIRATORY DISEASE CONTAINING A MIXED HERBAL EXTRACT OF CNIDIUM OFFICINALE ROOT AND POLYGONI CUSPIDATI ROOT

Номер: US20140030368A1
Автор: Cho Yong Baik, Hur Jong Hyun, Hyon Min-Kyong, JUNG In Ho, JUNG Kyoung Chul, Kang Moon Kyu, Kim Seul Ki, Kim Soon Han, Lee Je Young, LEE JEE YOUNG, Yu Byung Chul
Принадлежит: WHANIN PHARMACEUTICAL CO., LTD.

The present invention relates to a composition for preventing or treating a respiratory disease containing an active ingredient in the form of a mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix, and relates to a production method therefor. The mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix has an outstanding 5-lipoxygenase suppressing activity, airway constriction suppressing activity, airway inflammation suppressing action, ear-swelling anti-inflammatory effect and antitussive and phlegm-loosening action, and has been confirmed to be useful in preventing or treating respiratory diseases including asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, allergic rhinitis, cough, expectoration, acute lower respiratory infections (bronchitis and bronchiolitis), and acute upper respiratory infections such an pharyngitis, tonsillitis and laryngitis. 1. A composition for preventing or treating respiratory disease , which contains , as an active ingredient , an extract obtained by extracting a mixture of Cnidii rhizoma and Polygoni cuspidati radix with a Cto Clower alcohol or a 10-95% aqueous solution of the alcohol.2. The composition of claim 1 , wherein the extract is an extract solubilized with a solvent selected from the group consisting of ethyl acetate claim 1 , dichloromethane and butanol.3. The composition of claim 1 , wherein the mixing weight ratio between Cnidii rhizoma and Polygoni cuspidati radix is 0.1:1 to 10:1 (Cnidii rhizoma:Polygoni cuspidati radix).4. The composition of claim 3 , wherein the mixing weight ratio between Cnidii rhizoma and Polygoni cuspidati radix is 0.5:1 to 5:1.5. The composition of claim 1 , wherein the respiratory disease is selected from the group consisting of asthma claim 1 , chronic obstructive pulmonary disease claim 1 , allergic rhinitis claim 1 , pyothrox claim 1 , lung abscess claim 1 , coughing claim 1 , phlegm claim 1 , bronchitis claim 1 , laryngopharyngitis claim ...

Подробнее
Номер записи: 72
06-02-2014 дата публикации

HERBAL FORMULATIONS

Номер: US20140037765A1
Автор: MAIMON Yair N.
Принадлежит: LIFE BIOTECH MEDICAL RESEARCH LTD

Provided is a formulation including a variety of Chinese herbs for the treatment of a disease, such as cancer, and side effects associated with the treatment of the disease. 170.-. (canceled)71. A herbal formulation comprising a combination of at least four herbs , each being selected from:at least one herb that tonifies the Qi;at least one herb that drains dampness;at least one herb that tonifies blood;at least one herb that invigorates the blood;at least one herb that regulates the flow of Qi;at least one herb that tonifies yin;at least one herb that clears heat and relieves toxicity; andat least one herb that clears heat and firewhereinthe at least one herb that tonifies the Qi is selected from the group consisting of Astragalus Membranaceus (Huang QI), Atractylodes Macrocephala (Bai zhu), Ginseng Radix (Ren Shen), Radix Codonopsitis Pilosulae (Dang Shen), Pseudostellaiae Heterophillae(Tai Zi Shen) and Redix Glycyrrhizae Uralensis (Gan Cao);the at least one herb that drains dampness is selected from the group consisting of Poriae Cocos (Fu Ling), Coicis Lachryma-jobi Semen (Yi Yi Ren), Herba Lobeliae Chinensis Cum Radice (Ban Bian Lian), Semen Plantaginis (Che Qian Zi), Fructus Kochia Scopariae (Di Fu Zi) and Rhizoma Alismatis (Ze Xie);the at least one herb that tonifies blood is selected from the group consisting of Lycium Chinense (Gou Qi Zi), Radix Paeoniae Lactiflorae (Bai Shao), Radix Angelica Sinensis (Dang Gui), Arilus Euphoriae Longanae (Long Yang Rao), Mori Albae Fructus (Sang Shen) and Rhemanniae Glutinosae Conquitae Radix (Shu Di Huang);the at least one herb that invigorates the blood is selected from the group consisting of Paeonia Obovata (Chi Shao), Radix Salviae Miltiorrhizae (Dan Shen), Radix Ligustici Chuanxiong (Chuanxiong), Flos Carthami Tinctorii (Homg Hua), Radix Et Caulis Jixueteng (Ji Xue Tang), Curcumae, Tuber (Yu Jin), Persicae, Semen (Tao Ren) and Curcuma Zedoaria (E-Zhu);the at least one herb that regulates the flow of Qi is selected ...

Подробнее
Номер записи: 73
06-02-2014 дата публикации

Natural - Topical analgesic and anti-inflammatory composition F2

Номер: US20140037767A1
Автор: Hutsell Michael Wayne, Mills Michelle
Принадлежит:

This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties. 1Helicrysum GymnocephalumSalix AlbaEucalyptus GlobulesLavandula AngustifoliaPelargonium GraveoleusMentha viridisMentha Avrensis,. As described in U.S. patient application Ser. No. 13/565 ,676 filed on Aug. 2 , 2012 , the combination of essential oil and extract when combined with essential oil , essential oil , essential oil , essential oil , Camphor , and incorporated into a cosmetic cream substrate , together constitute a unique and effective topical pain relief product.2Pimenta Racemosa,Cymbopogon flexuosus. It has been found that the effects of the compound described in above are enhanced by the addition (Dominican Bay Leaf) claim 1 , (Lemon Grass) to said compound. Test subjects reported that the enhanced compound provides a higher level of temporary pain relief claim 1 , that it is longer lasting. This is a continuation of U.S. patent application Ser. No. 13/565,676 dated 2013 Aug. 2.This invention is intended provide an alternative to synthetic topical pain relief preparations. This invention contains natural, botanical extracts and essential oils in lieu of synthetic analgesics and fragrance, replacing synthetic salicin based anti-inflammatory preparations.The invention is an emulsion of natural trans-dermal carriers and analgesic and anti-inflammatory components including (White Willow Bark) extract. The cream is compounded by combining the jojoba oil base with (White Willow Bark), the natural botanical extracts (Lavender), (Egyptian ), (Spearmint), (), (Rosemary), (Dominican Bay Leaf), (Lemon Grass), crystaline menthol and crystaline ...

Подробнее
Номер записи: 74
13-02-2014 дата публикации

Method of Obtaining Hemp Plant Juice and Use of Same for the Production of Beverages

Номер: US20140044807A1
Автор: Bisterfeld Von Meer Galathea Ute
Принадлежит: CLAREMONT COLLECTION HANDELSGESELLSCHAFT MBH

The present invention relates to a method for producing beverages on the basis of juice from the hemp plant. The invention relates to a method for obtaining juice suitable for human consumption from the hemp plant, wherein the complete hemp stem is pressed after harvest without prior drying or retting. The invention further provides a method for obtaining juice from the hemp plant, wherein the upper leafy part of the hemp plant is cut, the leaves are stripped of the remaining stem, fibres and shives being separated from each other at the stem, the leafy part of the stem, the fibres and the shives being pressed individually under pressure and the so obtained pressed juices are being mixed in a controlled manner. In a yet further aspect, the invention relates to a method for the manufacturing of beverages on the basis of juice from the hemp plant, wherein the hemp juice is mixed with yeast and than fermented. 1. Method for obtaining juice from a hemp plant comprising the steps of harvesting the hemp prior to the seed ripening , and pressing the complete hemp stem without any previous drying or retting.2. Method for obtaining juice which is suitable for human consumption from a hemp plant comprising the steps ofa) harvesting the hemp prior to the seed ripening;b) cutting the upper leafy part of the stem;c) stripping the leaves from the remaining stem;d) separating fibres and shives from each other at the stems;e) pressing the leafy part of the stem, the fibres and the shives separately under pressure; andf) mixing the so obtained juices.3. Method of claim 1 , wherein said pressing of the hemp plant or said pressing of the leafy part of the stems claim 1 , fibres and/or shives is carried out under a pressure of 10 to 300 bar.4. Method according to claim 1 , wherein said pressing of the hemp plant or said pressing of the stems claim 1 , fibres and/or shives is carried out by use of an extruder.5. Method according to claim 2 , wherein in step a) about ⅓rd to ¼th of the ...

Подробнее
Номер записи: 75
13-02-2014 дата публикации

DIETETIC OR PHARMACEUTICAL PREPARATION CONTAINING TARTARY BUCKWHEAT

Номер: US20140044808A1
Автор: Kehr Wolfgang, Thiede Hans-Michael
Принадлежит: THANARES GMBH

The invention relates to a method for preparing a dietetic or pharmaceutical composition, comprising the following steps: a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature, b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., and c) subsequently to step b), the mixture is cooled down to a temperature below 45° C. The invention further relates to thus obtainable preparations and to the uses thereof. 1. A method for preparing a dietetic or pharmaceutical composition , comprising the following steps:a) a preparation containing rutin, in particular ground tatary buckwheat, is mixed with a protein solution in a weight ratio protein solution/buckwheat from 1 to 100 (or vice versa), wherein before the addition of buckwheat, the protein solution has been heated above room temperature,b) the mixture from step a) is held for a period of at least 10 to 1,000 s at a temperature >50° C., andc) subsequently to step b), the mixture is cooled down to a temperature below 45° C.2. The method according to claim 1 , wherein the weight ratio protein solution/buckwheat is from 4 to 20.3. The method according to claim 1 , wherein the room temperature is in the range from 5 to 40° C.4. The method according to claim 1 , wherein the protein solution is selected from the group consisting of milk of cows claim 1 , buttermilk claim 1 , milk of camels claim 1 , milk of mares claim 1 , milk of goats claim 1 , milk of donkeys claim 1 , milk of llamas claim 1 , milk of reindeers claim 1 , milk of water buffaloes and milk of sheep claim 1 , soy milk claim 1 , coconut milk and lactose-free milk of the above types of milk.5. The method according to claim 1 , wherein the protein solution has a fat content from 0.5 to 8% ...

Подробнее
Номер записи: 76
13-02-2014 дата публикации

ANTACID FORMULATIONS AND ASSOCIATED METHODS

Номер: US20140044809A1
Автор: Brainard Elliott F.
Принадлежит:

The present invention provides antacid compositions and associated methods. In one aspect for example, an antacid composition suitable for delivery to a subject for reducing a digestive condition includes an effective amount of at least one citrate compound, an effective amount of blueberry product, and an effective amount of fruit extract including a member selected from the group consisting of pomegranate extract, bilberry extract, elderberry extract, blueberry extract, and combinations thereof. 1. An antacid composition suitable for delivery to a subject for reducing a digestive condition , comprising:an effective amount of at least one citrate compound;an effective amount of a blueberry product selected from the group consisting of blueberry fiber, blueberry fruit, and combinations thereof; andan effective amount of fruit extract including a member selected from the group consisting of pomegranate extract, bilberry extract, elderberry extract, blueberry extract, and combinations thereof.2. The composition of claim 1 , wherein the citrate compound is selected from the group consisting of magnesium citrate claim 1 , calcium citrate claim 1 , sodium citrate claim 1 , potassium citrate claim 1 , and combinations thereof.3. The composition of claim 1 , wherein the citrate compound includes magnesium citrate and calcium citrate.4. The composition of claim 1 , wherein the fruit extract includes at least two members selected from the group consisting of pomegranate extract claim 1 , bilberry extract claim 1 , elderberry extract claim 1 , blueberry extract claim 1 , and combinations thereof.5. The composition of claim 1 , wherein the fruit extract includes pomegranate extract claim 1 , bilberry extract claim 1 , and elderberry extract.6. The composition of claim 5 , wherein the fruit extract includes blueberry extract.7. The composition of claim 1 , wherein the blueberry product is blueberry fiber and the composition is formulated as a member selected from the group ...

Подробнее
Номер записи: 77
13-02-2014 дата публикации

Method and process for relieving or preventing symptoms

Номер: US20140044811A1
Автор: Abernathy Susan M., Truscott Kent J.
Принадлежит:

A method for relieving or preventing symptoms associated with uric acid crystals, comprising consuming a formulation that supports three or more processes, the processes comprising: 1. A method for relieving or preventing symptoms associated with uric acid crystals , comprising consuming a formulation that supports three or more processes that reduce a symptom due to uric acid crystals in a body , the processes comprising:1) a process that inhibits formation of uric acid in the body;2) a process that increases elimination of uric acid from the body; and3) a process that interferes with formation of uric acid crystals in the body.2. The method of claim 1 , wherein the formulation comprises an extract of celery claim 1 , an extract of cherry claim 1 , and a lithium salt.3. The method of claim 2 , wherein the extract of celery is from a seed.4. The method of claim 2 , wherein the extract of cherry is from a fruit.5. The method of claim 2 , wherein the lithium salt is selected from the group consisting of lithium orotate claim 2 , lithium aspartate claim 2 , lithium proteinate claim 2 , lithium citrate claim 2 , lithium carbonate claim 2 , and mixtures thereof.6. The method of claim 5 , wherein the lithium salt is selected from the group consisting of lithium orotate claim 5 , lithium aspartate claim 5 , lithium proteinate claim 5 , and mixtures thereof.7. The method of claim 2 , wherein the formulation comprises from 25 to 200 mg of extract of celery claim 2 , from 100 to 1500 mg extract of cherry claim 2 , and from 1.5 to 10 mg of elemental lithium in the lithium salt; and wherein the formulation is consumed from one to four times per day.8. The method of claim 2 , wherein the formulation comprises from 1.5 to 10 mg of elemental lithium in the lithium salt.9. The method of claim 1 , wherein the formulation is consumed from once every other day to once per day.10. The method of claim 1 , wherein the extract of celery is standardized to contain at least 50% 3-n- ...

Подробнее
Номер записи: 78
20-02-2014 дата публикации

COLD INFUSION PROCESS FOR FORTIFYING CORN AND/OR SOYBEANS

Номер: US20140050804A1
Автор: Sweeney Michael B.
Принадлежит: Voyava Republic LLC

This invention relates to a cold infusion process for fortifying corn and/or soybeans with one or more vitamin, non-vitamin, mineral, non-mineral, botanical, hormone, herb, neutraceutical, lipid, carbohydrate, amino acid, acid, salt, prebiotic, or probiotic functional additives. This invention also discloses an infused corn and/or soybean produced by the process of infusing the corn and/or soybean at a temperature of less than about 120° F. with a solution comprising water, a bridge initiator for acid salt bias, fortifying agent(s), and an acid in a quantity sufficient to reach a pH of about 3.65. Further, this invention provides a method for the infusion of a corn and/or soybean with at least one fortifying agent at approximately room temperature. 1. A method for the infusion of a corn with at least one fortifying agent comprising the steps of:a.) roasting the corn;b.) allowing the corn to cool to approximately room temperature;c.) preparing a fortifying solution comprising at least one fortifying agent, a bridge initiator for acid salt bias, an acid, and water, wherein the solution has a pH of between about 4 to about 3.5; andd.) mixing the roasted corn with the fortifying solution.2. The method of claim 1 , wherein the at least one fortifying agent is a vitamin claim 1 , non-vitamin claim 1 , mineral claim 1 , non-mineral claim 1 , botanical claim 1 , hormone claim 1 , herb claim 1 , neutraceutical claim 1 , lipid claim 1 , carbohydrate claim 1 , amino acid claim 1 , acid claim 1 , salt claim 1 , prebiotic claim 1 , or probiotic.3. The method of claim 1 , wherein the solution further comprises about 3500-4000 g of water claim 1 , about 80-110 g of betaine claim 1 , about 150-1500 g of at least one fortifying agent claim 1 , and citric acid in a quantity sufficient to reach a pH of about 3.65 per gallon of solution.4. The method of claim 1 , wherein the fortifying solution comprises a plurality of fortifying agents.5. The method of claim 1 , wherein the fortifying ...

Подробнее
Номер записи: 79
06-03-2014 дата публикации

Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder

Номер: US20140065216A1
Автор: Joseph M. Fuisz, Richard C. Fuisz
Принадлежит: Individual

A bioactive dose for delivering a bioactive agent to a mammal, includes a solid bioactive dosage unit containing at least one bioactive agent and a rapid release coating provided on at least one outer surface of the solid bioactive dosage unit, the rapid release coating containing a material having a property of rapidly modulating a pH of bodily fluids in which the material comes in contact in a direction towards an ideal absorptive pH or towards an ideal pH to hinder absorption of the at least one bioactive agent given the pKa that least at one bioactive agent. A modified liquid that is administered prior to, contemporaneous with, or following the delivery of a bioactive agent is also described. The liquid includes a pH modifier selected to control the pH of the liquid to a predetermined range so that the modified liquid rapidly modulates the pH of bodily fluids to enhance or hinder absorption of the bioactive agent.

Подробнее
Номер записи: 80
06-03-2014 дата публикации

Methods for Radiation Protection

Номер: US20140065247A1
Автор: DJANG ARTHUR H.K.
Принадлежит: Sante International, Inc.

Provided is a method for protecting an individual against radiation-induced internal damage that comprises administering an effective amount of an oral composition. The oral composition comprises a mixture of (hawthorn), and (green tea) to an individual so that radiation-induced internal damage will be prevented or ameliorated. 1Gynostemma pentaphyllum, Crataegus pinnatifidaCamellia sinensis. A method for protecting an individual against radiation-induced internal damage comprising administering an effective amount of an oral composition comprising a mixture of (hawthorn) , and (green tea) to an individual so that radiation-induced internal damage is prevented or ameliorated.2Gynostemma pentaphyllum,Camellia sinensisCrataegus pinnatifida. The method according to wherein the composition comprises about 10 to about 30 percent by weight of about 10 to about 30 percent by weight of (green tea) claim 1 , and about 40 to about 75 percent by weight of (hawthorn).3Gynostemma pentaphyllum,Camellia sinensisCrataegus pinnatifida. The method according to wherein the composition comprises about 10 to about 30 percent by weight of a mixture of an aqueous extract and an alcohol extract of about 10 to about 30 percent by weight of a mixture of an aqueous extract and an alcohol extract of (green tea) claim 1 , and about 40 to about 75 per-cent by weight of a mixture of an aqueous extract and an alcohol extract of (hawthorn).4. The method according to wherein the radiation is ionizing radiation selected from the group consisting of alpha radiation claim 1 , beta radiation claim 1 , gamma radiation claim 1 , neutron radiation claim 1 , X-ray and a combination thereof.5. The method according to wherein the effective amount is a prophylactically effective amount administered before exposure to radiation.6. The method according to wherein the effective amount is a therapeutically effective amount administered at one or more times of during radiation exposure claim 1 , and after radiation ...

Подробнее
Номер записи: 81
06-03-2014 дата публикации

TNF-ALPHA INHIBITOR

Номер: US20140065251A1
Автор: Binachon Christophe
Принадлежит: ESPRIT D'ETHIQUE

An anti-inflammatory composition for inhibiting the secretion of cytokines, with the composition being based on a decoction of papaya leaves, a method of obtaining such a composition and a method of manufacturing an anti-inflammatory remedy for inhibiting cytokine secretion, having the composition the anti-inflammatory composition as its active principle. The method of obtaining the composition includes the steps of producing a decoction from papaya leaves, filtering the decoction in order to obtain a filtrate and atomizing the filtrate. 1. A composition based on a decoction of papaya leaves , used as an agent for inhibiting the secretion of pro-inflammatory cytokines during an inflammatory reaction.2. The composition according to claim 1 , used as an agent for inhibiting a secretion of TNF-α during an inflammatory reaction.3. The composition according to claim 1 , prepared in order to increase pH at least in the inflamed zone.4. The composition according to claim 1 , used as an a inflammatory agent for the ENT region.5. The composition according to claim 4 , used to reduce claim 4 , limit claim 4 , or curb the inflammatory reaction caused by an infection of the mouth such as gingivitis or periodontitis.6. The composition according to claim 4 , used to reduce claim 4 , limit claim 4 , or curb the inflammatory reaction caused by an infection of the nose such as rhinitis or sinusitis.7. The composition according to claim 1 , used to reduce claim 1 , limit claim 1 , or curb an inflammatory reaction of the eye.8. The composition according to claim 1 , formed by a dry extract of said decoction.9. The composition according to claim 1 , in the form of a powder.10. The composition according to claim 9 , wherein the powder is in suspension in an aqueous solution.11. The composition according to claim 1 , packaged into the form of tablets.12. The composition according to claim 1 , packaged for nebulization onto an inflamed zone.13. The composition according claim 1 , packaged ...

Подробнее
Номер записи: 82
13-03-2014 дата публикации

METHODS OF TREATMENT USING THYMUS-DERIVED COMPOSITIONS

Номер: US20140072651A1
Автор: Ushijima Richard N.
Принадлежит: CMI RESEARCH MANAGEMENT, LLC

Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of extracts and the use of those extracts as an anti-emetic and/or anti-nausea treatment for a subject in need thereof. 1. A method for preparing heat-treated , fractionated thymus extract composition , comprising:homogenizing thymus tissue with aqueous homogenization fluid to produce an aqueous thymus homogenate;removing tissue debris from the aqueous thymus homogenate to produce a primary supernatant;heat denaturing the primary supernatant, and clarifying the denatured primary supernatant by use of at least one of low-speed centrifugation and filtration, to produce a clarified supernatant; andseparating molecules having molecular weights less than about 3.5 kDa from the clarified supernatant, wherein a heat-treated, fractionated thymus extract composition lacking proteins or polypeptides having molecular weights less than about 3.5 kDa is provided.2. The method of claim 1 , further comprising separating molecules having molecular weights greater than about 30 kDa from the heat-treated claim 1 , fractionated thymus extract composition claim 1 , wherein a heat-treated claim 1 , fractionated thymus extract composition comprising proteins or polypeptides having molecular weights in the range of about 3.5 kDa to about 30 kDa is provided.3. The method of claim 1 , further comprising further clarifying of the clarified ...

Подробнее
Номер записи: 83
13-03-2014 дата публикации

DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF NELUMBO AND METHODS OF USING SAME

Номер: US20140072659A1
Автор: Miller Peter J., Qin Bolin, Romero Tim
Принадлежит: FHG Corporation d/b/a Integrity Nutraceuticals

Materials derived from are administered orally to humans or animals for the purpose of enhancing creatine transport into skeletal tissue and for purposes of enhancing lean body mass. Enhancing creatine transport through improved insulin signaling is a new method of depositing creatine and enhancing lean body mass. Such administration is also used for enhancing athletic performance and controlling bodyweight and body fat levels. More specifically, such administration is used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material is administered as extracts of and administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks. 1. A process of reducing body fat in a subject comprising:{'i': Nelumbo, Nelumbo', 'Nelumbo, 'administering to said subject a dietary supplement comprising extract, or a derivative of extract; and'}creatine, a creatine derivative, or a creatine precursor.2Nelumbo, NelumboNelumboNelumboNelumbo. The process of wherein said extract claim 1 , or a derivative of extract is a extract made by extracting plant in water.3. The process of wherein said composition is administered daily.4. The process of wherein said composition is administered daily for four to six weeks.5. The process of wherein said composition is administered more than one time per day.6Nelumbo. The process of wherein said extract is present from 10 milligrams to 1 claim 1 ,000 milligrams and said creatine is creatine monohydrate present from 2 grams to 25 grams.7NelumboNelumbo. The process of wherein said dietary supplement comprises a water extract of wherein said extract is made by extracting ground plant in water at a temperature from about 50 degrees Celsius to 100 degrees Celsius; andcreatine monohydrate.8. The process of wherein said dietary supplement is added to a liquid.9. The process of comprising administering said dietary supplement to said subject for a one week loading period ...

Подробнее
Номер записи: 84
13-03-2014 дата публикации

Andrographis Paniculata Compositions and Methods for Treatment of Addictions

Номер: US20140072662A1
Автор: Ciccocioppo Roberto
Принадлежит:

Methods and compositions for the treatment or prevention of addictions and impulse control disorders using , active substances contained therein and extracts thereof, alone or in combination with other therapeutic agents. The methods and compositions of the invention are useful in the treatment or prevention of addiction to substances, including alcohol, nicotine, marijuana, opioid agonists cocaine, and amphetamines, as well as impulse control disorders, including pathological gambling and pathological overeating. 1Andrographis paniculataAndrographis paniculata. A method of treating substance addiction or an impulse control disorder or reducing the likelihood of relapse use of an addictive substance or practice of a behavior associated with an impulse control disorder , comprising administering to a subject in need thereof a composition comprising an effective amount of or an active substance or extract of , wherein the composition is effective to treat the substance addiction or impulse control disorder or reduce the likelihood of relapse use of the addictive substance or practice of the behavior associated with the impulse control disorder.2Andrographis paniculata. The method of claim 1 , wherein the composition comprises an extract of in a solvent.3. The method of claim 1 , wherein the composition comprises dehydroandrographolide claim 1 , andrographolide or neoandrographolide.4. The method of claim 3 , wherein the composition comprises andrographolide.5. The method of claim 1 , where in the composition further comprises at least one polyunsaturated fatty acid that upregulates PPARγ.6. The method of claim 5 , wherein the composition comprises a polyunsaturated fatty acid selected from eicosapentaenoic acid claim 5 , conjugated linoleic acid and docosahexaenoic acid.7Cornus kousa, Cistus Salvifolius, Glycyrrhiza glabraAlbizia julibrissin, ArisaemaCnidium monnieri, Pinellia ternataTribulus terrestris. The method of claim 1 , wherein the composition further ...

Подробнее
Номер записи: 85
20-03-2014 дата публикации

COMPOSITION FOR ENHANCING MEMORY AND MITIGATING NEURODEGENERATION AND METHOD THEREOF

Номер: US20140079817A1
Автор: LIN CHE-HAO
Принадлежит: SUN PLAZA INTERNATIONAL CO., LTD.

The present invention provides a composition for enhancing memory and mitigating neurodegeneration comprising an effective amount of a extract. Also disclosed is a method thereof for enhancing memory and mitigating neurodegeneration comprising administering to a subject in need thereof an effective amount of a extract. The composition and method of the present invention is useful in treating Alzheimer's disease. 1Ludwigia octovalvis. A composition for enhancing memory and mitigating neurodegeneration comprising an effective amount of a extract.2Ludwigia octovalvisLudwigia octovalvisLudwigia octovalvis. The composition of claim 1 , wherein the extract is a water extract or a alcohol extract.3Ludwigia octovalvisLudwigia octovalvis. The composition of claim 2 , wherein the extract is a ethanol extract.4Ludwigia octovalvis. The composition of claim 1 , wherein the extract is prepared by a method comprising the following steps:{'i': 'Ludwigia octovalvis', '(i) extracting with a first solution to obtain an extract solution and a residue; and'}(ii) removing the residue.5. The composition of claim 4 , wherein in step (i) the first solution is at a temperature of 2-10° C.6Ludwigia octovalvis. The composition of claim 4 , wherein in step (i) the is extracted for 4-12 hours.7Ludwigia octovalvis. The composition of claim 6 , wherein in step (i) the is extracted for 4-12 hours and then is heated for 10-60 minutes.8. The composition of claim 4 , wherein the first solution is water or an alcohol solution.9. The composition of which enhances short-term memory or long-term memory.10. The composition of which is used for treating Alzheimer's disease.11Ludwigia octovalvis. A method for enhancing memory and mitigating neurodegeneration comprising administering to a subject in need thereof an effective amount of a extract.12Ludwigia octovalvisLudwigia octovalvisLudwigia octovalvis. The method of claim 11 , wherein the extract is a water extract or a alcohol extract.13Ludwigia ...

Подробнее
Номер записи: 86
20-03-2014 дата публикации

BOEHMERIA EXTRACT AND ITS USE IN TREATING LIVER DISEASES

Номер: US20140079818A1
Автор: LEE Lain-Tze, Lin Meng-Nan, Liu Wan-Chun, Shih Ying-Chu, TSAI Hui-Ping
Принадлежит: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE

A method for treating liver fibrosis. The method includes administering to a subject suffering from liver fibrosis a pharmaceutically active extract obtained from a species. Also disclosed is a method for regenerating liver tissue and a method for improving a liver function. 1. A method for treating liver fibrosis , the method comprising:identifying a subject suffering from liver fibrosis;{'i': Boehmeria', 'Boehmeria', 'Boehmeria, 'providing a pharmaceutically active extract obtained from a species by the steps consisting essentially of immersing a part of the species in water at a temperature of 20° C.-70° C., removing the part of the species to obtain a solution, and concentrating the solution to form the pharmaceutically active extract; and'}{'i': 'Boehmeria', 'administering the pharmaceutically active extract to the subject, wherein the pharmaceutically active extract is the only extract from a species that is administered to the subject.'}2BoehmeriaBoehmeria niveaBoehmeria frustescens thunberg.. The method of claim 1 , wherein the species is or3. The method of claim 2 , wherein the immersing step is performed for 2-24 hours and the water is at a temperature of 25° C.-40° C.4. The method of claim 1 , wherein the solution is concentrated to a solid content of at least 20% by weight.5. The method of claim 1 , wherein the immersing step is performed for 2-24 hours and the water is at a temperature of 25° C.-40° C.6. A method for regenerating liver tissue in a subject claim 1 , the method comprising:identifying a subject in need of liver tissue regeneration;{'i': Boehmeria', 'Boehmeria', 'Boehmeria, 'providing a pharmaceutically active extract obtained from a species by the steps consisting essentially of immersing a part of the species in water at a temperature between 20° C.-70° C., removing the part of the species to obtain a solution, and concentrating the solution to form the pharmaceutically active extract; and'}{'i': 'Boehmeria', 'administering the ...

Подробнее
Номер записи: 87
20-03-2014 дата публикации

METHODS AND COMPOSITIONS FOR ALTERING HEALTH, WELLBEING, AND LIFESPAN

Номер: US20140079836A1
Автор: McDaniel David H.
Принадлежит:

Described herein are the results of comprehensive genetic expression and other molecular analysis of the effect of antioxidants on biological systems, including specifically different human cells. Based on these analyses, methods and compositions are described for modifying or influencing the lifespan of cells, tissues, organs, and organisms. In various embodiments, there are provided methods for modulating the activity of the gene maintenance process in order to influence the length and/or structural integrity of the telomere in living cells, as well as methods for modulating the rate/efficiency of the cellular respiration provided by the mitochondria, mitochondrial biogenesis, and maintenance of the mitochondrial membrane potential. Exemplary lifespan altering compounds include natural and synthetic antioxidants, such as plant antioxidant and polyphenol compounds derived from coffee cherry, tea, berry, and so forth, including but not limited to caffeic acid, chlorogenic acid, ferulic acid, quinic acid, proanthocyanidins, ubiquinone, idebenone, or a synthetic form or derivatives thereof. 1. A method for modulating the lifespan of a cell , tissue , organ or organism , or of increasing or decreasing cellular respiration and/or capacity and/or biogenesis of mitochondria in a cell , tissue , organ or organism , comprising contacting the cell , tissue , organ or organism with at least one lifespan modulating agent selected from the group consisting of:idebenone, or an analog or derivative thereof;a cocoa extract;a coffee cherry extract;quinic acid, or an analog or derivative thereof;ferulic acid, or an analog or derivative thereof;a proanthocyanidin, anthocyanidin, procyanidin, or cyanidin;chlorogenic acid, or an analog or derivative thereof;a tea extract; orresveratrol or a composition derived from or chemically related to resveratrol.2. The method of claim 1 , wherein modulating comprises modulating the level and/or activity of:(a) ten or more of the genes listed as ...

Подробнее
Номер записи: 88
27-03-2014 дата публикации

BIOLOGICALLY ACTIVE DIETARY SUPPLEMENT FOR NORMALIZING THE ANDROGEN LEVEL IN MEN AND THE OVERALL CONDITION AND REDUCING OBESITY

Номер: US20140086999A1
Автор: Elistratov Dmitry Gennadjevich
Принадлежит:

Biologically active dietary supplements (BADS) are proposed for normalizing the hormone balance and the overall condition in men based on natural ingredients. The BADS contain white cinquefoil roots and rhizomes or the above-ground part of white cinquefoil, or a mixture thereof, as well as drone brood in a quantity of from 20 mass % to 80 mass %. The disclosure makes it possible to produce a product which demonstrates, by virtue of an optimally selected ratio of ingredients, a synergistic effect in relation to the normalization of the androgen level and the prophylaxis of obesity in men. 1 aerial portions of white cinquefoil, or', 'mixture thereof; and, '(a)—roots and rhizomes of white cinquefoil, or'}(b) drone brood in the weight proportion of: from 20 wt % to 80 wt %.. A biologically active dietary supplement for normalizing the androgen levels in men, improving general health and reducing obesity, said dietary supplement comprises: This application is a U.S. national stage application of an international application PCT/RU2011/000294 filed on 3 May 2011, published as WO2012150872, which international application claims priority of a Russian Federation patent application RU2010117666 filed on 3 May 2011.The invention relates to food industry, namely, to biologically active dietary supplements (BADS) used for normalization of hormonal profile and general health in men and produced based on natural ingredients.A prior art search on this matter showed the existence of large number of known herbal-based agents and promoting the normalization of hormonal profile and metabolic processes.There is known a broad-spectrum treatment and prevention remedy containing propolis and milk thistle oil (Patent of Russian Federation No. 2175238, A 61 K 35/78). Due to the claimed combination of its ingredients, this biologically active supplement is effective in terms of its ergogenic action, stimulation of mental and physical activity and natural resistance of the body, and ...

Подробнее
Номер записи: 89
27-03-2014 дата публикации

COMPOSITION FOR PREVENTING OR TREATING DEMENTIA COMPRISING EXTRACTS OF MONSONIA SPECIES

Номер: US20140087008A1
Автор: CHA Jin Wook, Chung Sung-Kwon, FOUCHE Gerda, Ham Jungyeob, KHOROMBI Eric, KIM Joon Ki, Kim Young-Joo, Kwon Hak Cheol, MAHARAJ Vinesh Jaichand, NAIDOO Dashnie, NTHAMBELENI Rudzani, SENABE Jeremiah, Yang Hyun Ok
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing and/or treating dementia comprising extracts of sp.; a food composition for preventing and/or improving dementia comprising extracts of sp.; and a method of preparing an extract of sp. with excellent inhibitory effect on the formation of β-amyloid. The plant extract can inhibit the formation of β-amyloid which has been known as a factor causing the dementia, especially Alzheimer's disease, thereby being used for preventing, improving and/or treating the dementia. 1. A composition for preventing , treating , improving and/or ameliorating a condition associated with β-amyloid in brain , comprising of at least an active ingredient selected from the group consisting of{'i': Monsonia angustifolia', 'Monsonia brevirostrate;, 'an extract of at least a plant selected from the group consisting of and'}a dried product of the extract; anda concentrated product of the extract.2. The composition of claim 1 , wherein the composition is a pharmaceutical composition for preventing and/or treating the condition associated with β-amyloid in brain.3. The composition of claim 1 , wherein the composition is a food composition for preventing or improving the condition associated with β-amyloid in brain.4. The composition of claim 3 , wherein the food composition is health functional foods claim 3 , beverage claim 3 , food additives claim 3 , or beverage additives.5. The composition of claim 1 , wherein the condition associated with β-amyloid in brain is selected from the group consisting of dementia claim 1 , memory and memory impairment.6. The composition according to claim 1 , wherein the extract is obtained by extracting with at least a solvent selected from the group consisting of water claim 1 , a linear or branched alcohol having 1 to 4 carbon atoms claim 1 , ethyl acetate claim 1 , dichloromethane claim 1 , and acetone.7. The composition according to claim 1 , wherein the plant extract is obtained by ...

Подробнее
Номер записи: 90
27-03-2014 дата публикации

Method and external preparation for lymphatic slimming

Номер: US20140088548A1
Автор: Satoshi Shinkawa
Принадлежит: Individual

The present invention provides a set of body slimming compositions, for application to a body before irradiating the body with a far-infrared ray in an atmosphere of 50° C. or thereabout. The slimming composition set includes a first external composition containing a cosmetic base, a Bacillus-fig-soybean fermented liquor, a Bacillus-Monascus-angelica-soybean fermented liquor, a Bacillus-longan-soybean fermented liquor, orizanol, tocopheryl acetate, macadamia nut oil, and glucosyl hesperidine, and a second external composition containing a cosmetic base, a Bacillus-persimmon-soybean fermented liquor, a Waltheria indica leaf extract, and ascorbyl tetrahexyldecanoate. The first external composition is applied to a lymphatic node region of the body, and the second external composition is applied to a slimming target region of the body. The composition set of the invention can activate lymph or lipase, whereby a remarkable body slimming effect can be attained.

Подробнее
Номер записи: 91
03-04-2014 дата публикации

Composition of Extract of Emblica Officinalis and Method of Preparing the Same

Номер: US20140093595A1
Автор: Antony Benny
Принадлежит:

The present disclosure relates to a composition of an extract of fruits of selected from the group consisting of liquid juice of fruits of , a powder of an alcoholic extract of fruits of , a powder of a hydro alcoholic extract of fruits of , a powder of a water extract of fruits of , a powder of a juice of fruits of , a powder of dried fruits of , a powder of a water extract of dried fruits of , a powder of a pectinase treated water extract of fruits of and combinations thereof; a method of preparing such compositions of extract of fruits of , more particularly which has application as a nutraceutical or pharmaceutical for increasing HDL-C levels in patients with memory loss and dementia especially in patients with neurodegenerative diseases like Alzheimer's disease and for the treatment of memory loss especially in Alzheimer's disease. 1Emblica officinalisEmblica officinalisEmblica officinalisEmblica officinalisEmblica officinalisEmblica officinalisEmblica officinalisEmblica officinalisEmblica officinalis.. An extract of fruits of selected from the group consisting of a liquid juice of fruits of , a powder of an alcoholic extract of fruits of , a powder of a hydroalcoholic extract of fruits of , a powder of a water extract of fruits of , a powder of a juice of fruits of , a powder of dried fruits of , a powder of a water extract of dried fruits of , and , a powder of a pectinase treated water extract of fruits of2Emblica officinalis. The extract of fruits of of claim 1 , comprising about 12% to 70% polyphenols.3Emblica officinalis. The extract of fruits of of claim 1 , comprising about 5% to about 35% hydrolysable gallo ellagic tannins.4Emblica officinalis. A dosage form comprising the extract of fruits of as claimed in claim 1 , wherein the dosage form selected from the group consisting of a capsule claim 1 , tablet claim 1 , granule claim 1 , sachet claim 1 , powder claim 1 , paste claim 1 , ointment claim 1 , infusion claim 1 , injection claim 1 , ampoule claim ...

Подробнее
Номер записи: 92
03-04-2014 дата публикации

USE OF ALCOHOL EXTRACT OF LONGAN SEEDS

Номер: US20140093597A1
Автор: HSIAO YI-TING, LIN JIAN-SHENG, Tseng Huang-Chung, YEN Chun-Yi, ZHAN YOU-ZHONG
Принадлежит: JOBEN BIO-MEDICAL CO., LTD.

The present invention provides use of alcohol extract of longan seeds for manufacturing a drug for treating kidney tissue dysfunction. Preferably, an ethyl acetate sub-fraction of the alcohol extract of longan seeds has a better effect in treating kidney tissue dysfunction. 1. A method for treating kidney tissue dysfunction in a subject , which comprises administering to said subject an effective amount of an alcohol extract of longan seeds and optionally a pharmaceutically acceptable carrier or excipient.2Dimocarpus longan Lour., Dimocarpus longanDimocarpus longan Fen Ke.. The method according to claim 1 , wherein the longan is or3. The method according to claim 1 , wherein the alcohol is selected from the group consisting of methanol claim 1 , ethanol claim 1 , n-propanol claim 1 , isopropanol claim 1 , n-butanol claim 1 , iso-butanol claim 1 , sec-butanol claim 1 , tert-butanol claim 1 , and ethyl acetate or the solution thereof.4. The method according to claim 1 , wherein the alcohol extract of longan seeds comprises a fraction obtained by flash column chromatography; the column is 40 g Silica; the flow rate is 18 mL/min; the mobile phase uses Solution A of ethyl acetate and Solution B of methanol; the gradient elution program is 100% Solution A and 0% Solution B at about 0 minute to about 30 minutes; 80% Solution A and 20% Solution B at about 31 minutes to about 45 minutes; 50% Solution A and 50% Solution B at about 46 minutes to about 65 minutes; 0% Solution A and 100% Solution B at about 66 minutes to about 85 minutes and at about 86 minutes to about 100 minutes.5. The method according to claim 4 , wherein the alcohol extract of longan seeds comprises a fraction obtained by flash column chromatography with the gradient elution program of 100% Solution A and 0% Solution B at about 0 minute to about 30 minutes.6. The method according to claim 1 , wherein the alcohol extract of longan seeds is prepared according to a process comprising:(a) providing longan seeds ...

Подробнее
Номер записи: 93
02-01-2020 дата публикации

Scorpion repel surface treatments and method for same

Номер: US20200000082A1
Автор: Aaron Gonzales, Tony Gonzales
Принадлежит: Individual

A system and method of applying a slick surface, such as silicone epoxy, is applied on a vertical wall (on or around the perimeter of a structure), as a means of preventing (bark) scorpions (or other insects/arachnids) from climbing up walls. The system is intended, in part, to keep the Arizona bark scorpions out of homes. Vertical surface areas around the home are treated with a material such as silicone. A clear silicone epoxy, that when dry, prevents scorpions from climbing vertically up into a home or structure. This non-toxic epoxy is applied to the base of a home, including door thresholds, steps or other parts of a home which makes contact with the ground. The epoxy is applied to the area by sprayer.

Подробнее
Номер записи: 94
07-01-2016 дата публикации

CAFFEINE-REDUCED CACAO COMPOSITION

Номер: US20160000110A1
Автор: KOBORI Kinji, MARUTA Yuto, MINEO Shigeru
Принадлежит:

The present invention relates to a caffeine-reduced cacao composition and a method for producing the same. According to the present invention, it is possible to provide a novel caffeine-reduced cacao composition in which only caffeine is selectively reduced while retaining a health functional component contained in a cacao raw material, and a method for producing the same. 1. A caffeine-reduced cacao composition obtained by subjecting at least one cacao raw material selected from cacao mass and cocoa powder to supercritical carbon dioxide extraction using water as a cosolvent , whereinthe concentration of theobromine in the composition is 0.7% by weight or more, andthe content of theobromine in the composition is 25 times or more of the content of caffeine.2. The caffeine-reduced cacao composition according to claim 1 , wherein the content of polyphenol in the caffeine-reduced cacao composition is 40 times or more of the content of caffeine.3. The caffeine-reduced cacao composition according to claim 1 , wherein the cacao raw material is not subjected to an alkali treatment.4. The caffeine-reduced cacao composition according to claim 1 , wherein the cacao raw material is cocoa powder.5. The caffeine-reduced cacao composition according to claim 1 , wherein supercritical carbon dioxide extraction is performed under the conditions of 20 MPa or more and 50° C. or higher.6. The caffeine-reduced cacao composition according to claim 1 , wherein the proportion of the cosolvent relative to the cacao raw material in supercritical carbon dioxide extraction is 30% by weight or more.7. The caffeine-reduced cacao composition according to claim 1 , wherein 90% by weight or more of the content of theobromine derived from the cacao raw material is retained claim 1 , and also 60% by weight or more of the content of caffeine derived from the cacao raw material is reduced.8. The caffeine-reduced cacao composition according to claim 1 , wherein 70% by weight or more of the content of ...

Подробнее
Номер записи: 95
06-01-2022 дата публикации

APPLE PEEL POLYPHENOL EXTRACT FOR THE PREVENTION AND THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Номер: US20220000959A1
Автор: LEAHY Michael, LEVY Emile
Принадлежит:

The present document describes apple peel polyphenolic extract comprising a proanthocyanidin content of at least 15000 μg/g of dry weight, comprising about 30% to about 35% epicatechin content, and pharmaceutical composition comprising the apple peel polyphenolic extract. The present document also describes methods and use of the apple peel polyphenolic extract for preventing or treating conditions such as oxidative stress, inflammation and mitochondrial dysfunction of the liver, insulin resistance, intestinal endothelial tissue injury, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH), liver fibrosis, liver cirrhosis, and/or inhibition of de novo lipogenesis and β-oxidation of free fatty acids for preventing accumulation thereof in the liver. The present document also describes a process for extraction of at least a polyphenol content from dry apple peel powder. 1. An apple peel polyphenolic extract comprisinga proanthocyanidin (PAC) content of at least 15000 μg/g of dry weight, comprising epicatechin momomers and oligomers having from about 1 to 5 epicatechin units, from about 3500 to 4000 μg/g of dry weight;', 'epicatechin oligomers having from about 6 to 10 epicatechin units, from about 1000 to 1100 μg/g of dry weight; and', 'epicatechin polymers having >10 epicatechin units, from about 500 to 600 μg/g of dry weight., 'an about 30% to about 35% epicatechin content comprising'}2. The apple peel polyphenolic extract of claim 1 , wherein said epicatechin momomers and oligomers having from about 1 to 5 epicatechin units comprises epicatechin monomers claim 1 , from about 700 to 800 μg/g of dry weight.3. The apple peel polyphenolic extract of claim 1 , wherein said epicatechin momomers and oligomers having from about 1 to 5 epicatechin units comprises epicatechin dimers claim 1 , from about 1000 to about 1200 μg/g of dry weight.4. The apple peel polyphenolic extract of claim 1 , wherein said epicatechin momomers and oligomers having from about 1 ...

Подробнее
Номер записи: 96
06-01-2022 дата публикации

PROCESS FOR PRESERVING THE HUSK AND USE OF RAMBUTAN (NEPHELIUM LAPPACEUM) IN FOOD PRODUCTS

Номер: US20220000960A1
Автор: Rojas Hider
Принадлежит: Rambuhealth Corp.

A formulation for delivering one or more health benefits to a human post-consumption and a method to create the formulation are described. The formulation comprises a shell extract of in a form of a powder or a liquid and at least one material. The at least one material comprises a polysaccharide, a protein, a lipid, and/or a food grade compound. The one or more health benefits to the human include support or regulation of blood sugar, blood pressure, body weight, performance/recovery from sports, immune health, anti-aging, pain management, and/or joint health. 1Nephelium lappaceum. A method to maintain a freshness of a shell of , the method comprising:{'i': 'Nephelium lappaceum', 'washing the shell of the with a first solution;'}{'i': 'Nephelium lappaceum', 'washing the shell of the with a component;'}{'i': Nephelium lappaceum', 'Nephelium, 'separating the shell of the from the lappaceum;'}{'i': 'Nephelium', 'packaging the shell of the lappaceum;'}{'i': 'Nephelium lappaceum', 'utilizing a means to decrease an enzymatic activity and a microbial activity of the packaged shell of the ; and'}{'i': 'Nephelium', 'storing the packaged shell of the lappaceum.'}2. The method of claim 1 , wherein the first solution is a neutral soapy solution.3. The method of claim 1 , wherein the component is selected from the group consisting of: a 100 parts per million chlorine solution claim 1 , quaternary ammonium compounds claim 1 , acetic acid claim 1 , peracetic acid claim 1 , and other non-toxic disinfectant.4Nephelium lappaceum. The method of claim 1 , wherein the packaging of the shell of the comprises vacuum packaging.5Nephelium lappaceum. The method of claim 1 , wherein the means to decrease the enzymatic activity and the microbial activity of the packaged shell of the comprises freeze shocking with air claim 1 , pressurized carbon dioxide claim 1 , or liquid nitrogen.6Nephelium lappaceum. The method of claim 1 , wherein the storing of the packaged shell of the occurs at a ...

Подробнее
Номер записи: 97
03-01-2019 дата публикации

ORGANIC NASAL TREATMENT SOLUTION

Номер: US20190000752A1
Автор: Johnson David, Spielberg Max
Принадлежит:

A nasal spray or therapy solution is provided having organic glycerin; an organic preservative system containing glycerin, fruit extract, fruit extract, peel extract, ascorbic acid, citric acid, lactic acid, water; sodium chloride; water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months. 1. A nasal spray or therapy solution comprising:1-4% w/w organic glycerin;{'i': citrus reticulata', 'citrus aurantium amara', 'citrus aurantium sinensis, '0.5-4% w/w of an organic preservative system containing Glycerin, fruit extract, fruit extract, peel extract, ascorbic acid, citric acid, lactic acid, water;'}0.2-1.0% w/w sodium chloride; and91-98.3% Water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.2. The nasal spray or therapy solution of comprising:1.5-2.5% w/w organic glycerin;{'i': citrus reticulata', 'citrus aurantium amara', 'citrus aurantium sinensis, '0.5-2% w/w of an organic preservative system containing Glycerin, fruit extract, fruit extract, peel extract, ascorbic acid, citric acid, lactic acid, water;'}0.4-0.7% w/w sodium chloride; and94.5-98% water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.3. A nasal spray or therapy solution consisting of:2.0% w/w organic glycerin;{'i': citrus reticulata', 'citrus aurantium amara', 'citrus aurantium sinensis, '0.5% w/w of an organic preservative system containing Glycerin, fruit extract, fruit extract, peel extract, ascorbic acid, citric acid, lactic acid, water;'}0.65% w/w sodium chloride; and96.5% water; whereby said nasal spray exhibits inhibited bacteriological growth in vitro for up to 36 months.4citrus reticulatacitrus aurantium amaracitrus aurantium sinensis. The nasal spray or therapy solution of claim 1 , wherein said organic preservative system comprises a component ratio: fruit extract:fruit extract:peel extract:glycerine:ascorbic acid:citric acid:lactic acid:water of ...

Подробнее
Номер записи: 98
04-01-2018 дата публикации

PREPARATION FOR PROTECTING AGAINST EXTRINSIC AND INTRINSIC SKIN AGING

Номер: US20180000722A1
Автор: DUDLER Bernhard, Stangl Daniel
Принадлежит:

Disclosed is a cosmetic or dermatological preparation which comprises one or more extracts of (purple saxifrage) and/or one or more extracts of (alpine snowbell). The use of these extracts to combat extrinsic and intrinsic skin aging is likewise described. 1Soldanella alpina. A cosmetic or dermatological preparation , wherein the preparation is suitable for topical application to human skin and for cosmetic and/or dermatological use , is present as at least one of a dispersion , gel , aqueous and/or alcoholic solution , serum , oil , tincture , ointment , salve or wipe impregnation media and comprises , based on a total weight of the preparation , from 0.0001% to 15% by weight of (i) one or more extracts of , as well as one or more components selected from fats , oils , waxes , moisturizing and/or humectant substances , alcohols , polyols , polymers , electrolytes , organic solvents , silicones , foam stabilizers , substances for preventing foaming , dyes , coloring pigments , thickeners.2Saxifraga oppositifolia.. The preparation of claim 1 , wherein the preparation further comprises from 0.0001% to 15% by weight of (ii) one or more extracts of3. The preparation of claim 2 , wherein the preparation comprises from 0.0001% to 1% by weight of (i) and/or from 0.0001% to 1% by weight (ii).4. The preparation of claim 1 , wherein (i) comprises at least one water-soluble extract obtained by hydro-alcoholic extraction of plant material.5. The preparation of claim 4 , wherein the plant material comprises plant leaves and/or plant stems.6. The preparation of claim 1 , wherein (i) comprises at least one oil-soluble extract obtained by supercritical fluid extraction of plant material.7. The preparation of claim 6 , wherein the plant material comprises plant leaves and/or plant stems.8. The preparation of claim 1 , in which all of the one or more extracts (i) are water-soluble or all of the one or more extracts (i) are oil-soluble.9Chlamydocapsa. The preparation of claim 1 , ...

Подробнее
Номер записи: 99
04-01-2018 дата публикации

COMPOSITIONS COMPRISING MAGNOLIA, PHELLODENDRON, THEANINE AND/OR WHEY PROTEIN

Номер: US20180000766A1
Автор: Bledsoe David, Griffin David, Henderson Todd
Принадлежит:

An anxiolytic composition includes a synergistic combination of one or more of an extract of magnolia, an extract of phellodendron, an L-theanine, a whey protein composition, and/or an s-adenosylmethionine (SAMe). 1. An anxiolytic composition , comprising a synergistic combination of L-theanine , a whey protein , an extract of magnolia , and an extract of phellodendron.2. The anxiolytic composition of claim 1 , wherein the whey protein comprises alpha-lactalbumin.3. The anxiolytic composition of claim 1 , wherein the synergistic combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.4. The anxiolytic composition of claim 3 , wherein the brain neurotransmitters are selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.5. The anxiolytic composition of claim 1 , formulated for oral administration to a mammal.6. The anxiolytic composition of claim 5 , wherein the mammal is selected from the group consisting of a human claim 5 , a companion animal claim 5 , and an equine animal.7. The anxiolytic composition of claim 1 , wherein the synergistic combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.8. The anxiolytic composition of claim 7 , wherein the brain neurotransmitters are selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.9. The anxiolytic composition of claim 1 , wherein the synergistic combination comprises RELORA.10. A method for reducing claim 1 , ameliorating claim 1 , or treating symptoms of anxiety claim 1 , comprising administration of a synergistic combination of L-theanine claim 1 , a whey protein claim 1 , an extract of magnolia claim 1 , and an extract of phellodendron to a mammal.11. The method of claim 10 , further including providing the whey protein as a whey protein concentrate comprising alpha-lactalbumin.12. The method of claim 10 , including orally administering the synergistic combination in an amount ...

Подробнее
Номер записи: 100